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Abstract 
Of the three forms of human Apolipoprotein E (ApoE2, ApoE3 and ApoE4), the &4 
allele coding for ApoE4 is associated with a higher risk of developing Alzheimer’s disease 
(AD) and an earlier age of onset, whereas &2 may be protective. The mechanisms underlying 
such influences are still unclear. 
This thesis has investigated the iiifluence of ApoE polymorphism on structural 
synaptic paraineters in the middle molecular layer (MML) of the dentate gyrus of wild type 
(WT), ApoE knockout (KO) and human ApoE (hApoE) transgenic mice, from 6 to 24 months 
of age using unbiased stei-eological inethods at the EM level. In hApoE4 mice, there was a 
349% decrease in the synapse per neuron ratio (Synhrn) accompanied by a 22% increase in the 
mean apposition zone area (inAZA) during aging. This pattern resembles closely the synaptic 
changes occurring early in AD, which have been correlated to the first symptoms of memory 
loss in humans. In contrast. there was no such synaptic loss in hApoE2, ApoE KO and WT 
inice. At old age, hApoE4 mice had the lowest s y d n r n  but their inAZA was comparable to 
that of «the[- groups. These data appear to be consistcnt with the view that possession of &4 is 
deleterious to cognitive functions in the elderly and AD patients. Notably, aged ApoE KO 
mice did not show any sign of synaptic degeneration, suggesting the involvement of other 
proteiiis to coinpensate for the luck of ApoE. At 18 inontlis old, hApoE2 inice have a greater 
hippocampal voluiiir and display the highest syidnrn and glutamate inimunogold labelling in 
presynaptic houtons and dendrites of the MML, compared to hApoE3 and hApoE4 mice. In 
AD patients, such effects of the &2 allele may act as a synaptic ‘reservoir’ and delay the onset 
of AD symptoms. 
T ~ L I S .  these lines of hApoE transgenic mice could provide a good basis for the future 
production of multiple transgenic mice in which to model AD pathogenesis. 
10 
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1.1 General introduction 
Twenty six years ago, ApoE was first described by Shore and Shore (Shore & Shore 
1973) as a component of very low density lipoprotein (VLDL) and initial interest focussed on 
its role in cholesterol-induced hyperlipidemia (Maliley 1983). Along with the discovery of the 
central role of ApoE in lipoprotein metabolism, additional roles have since been found in areas 
mch as neurobiology (Mahley 1988). The structure of ApoE and its expression in the brain are 
described in sections 1 .  I .  I and I .  1.2. The findings that support its involvement in various 
areas of neurobiology, with u particular emphasis on neuronal injury and Alzheimer’s disease 
(AD) are explored in sections 1.1.3 to 1.2. The bast section describes the current ApoE 
transgenic models used to study the mechanisms by which ApoE polymorphism influences the 
risk and age of onset of AD, and the outcome of head injury. 
1.1.1 ApoE structure. 
Apolipoprotein E (ApoE) is a 299- amino acid plasma glycoprotein with multiple 
biological properties. In huinans, there are 3 isoforins of ApoE. named ApoE?, E3 and E4. 
\vliicli are rncoded by 3 different alleles € 2 ,  &3 and €4 on chromosome 19. The 3 different 
ApoE isoformi differ by ;I siiigle imino acid substitution (Figure 1 .1  and Figure 1.2): ApoE2 
has cysteine rcsidues on positions 112 and 158, whereas ApoE.1 has an arginine at position 
I58 and ApoE4 has an arginine at both positions (Mahley 1988). In rodents however, only one 
ApoE isoform has been identified and it is most similar to the human ApoE4 protein 
(Rajavashisth et al. 1985). 3-dimensional structural studies of the different isofornx have 
shown that ai-ginine in position I I2 confers a typical conforniation to the ApoE4 protein and 
distinguishes it from ApoE2 and ApoE3 (Figure 1.2). This conformational difference is 
thought to underlie the differential effects of the ApoE isoforins on the CNS structure and 
function (Mahley & Huang 1999). 
12 


Every human individual caries 2 copies of the ApoE gene, one from each parent. Thus 
6 combinations are possible: ~ 2 / 2 ,  ~ 2 / 3 ,  ~ 3 / 3 ,  &2/4, ~ 3 / 4  and ~ 4 / 4  genotypes. In the general 
population, the most common allele is Apo&3 (78%), followed by &4 (15%) and €2 (7%) 
(Mahley 1988, Zannis et al. 1993). 
1.1.2 ApoE expression in the nervous system. 
In 1985, Elshourbagy et al (Elshourbagy et al. 1985) showed that ApoE was produced 
in abundance in the brain. ApoE was then shown to be associated with lipoproteins, and 
described us the principal lipid transport vehicle in cerebrospinal fluid (Pitas et al. 1987). 
Moreover, in peripheral nerve injury experiments, ApoE was induced at high concentration 
and appeared to play a key role in repair by redistributing lipids to regenerating axons and to 
Schwann cells during rernyelinization (Boyles et al. 1989, Ignatius et al. 1986). Taken 
together, these findings were the first indications that ApoE had a potential role in the central 
nervous system. 
In plasma and CSF, ApoE is associated with lipoproteins (Figure 1.3). These are 
inacroinoleculai- complexes generally composed of a phospholipid and free cholesterol shell 
surrounding it triglyceride and cholesteryl ester core in plasma, without triglyceride in CSF, 
and without either of these two molecules when secreted by astrocytes (Fagan et al. 1999, 
LaDu et al. 1998, Mahley 1988). Apolipoproteins such as ApoE stabilise the surface of 
lipoproteins, and serve as cofactors for enzymatic reactions and as ligands for cell surface 
receptors (Mahley 1988). 
Several studies have now shown the presence of immunoreactive ApoE in both 
neurons and glial cells in normal human and primate brain whereas it is essentially restricted 
to glial cells in normal rodent brain (Boyles et al. 1985, Diedrich et al. 1991, Han et al. 1994a 
(Han et al. 1994b, Ignatius et al. 1986, Poirier et al. 1991, Metzger et al. 1996, Rebeck et al. 
15 
1993, Xu et al. 1996, Xu et al. 1999a, Zarow & Victoroff 1998). At the ultrastructural level, 
glial and neuronal ApoE immunoreactivity is found in clumps in the cytoplasm and seems to 
be associated with the membrane of the endoplasinic reticulum or other organelles and cellular 
structures like mitochondria. Whereas astrocytes normally display a strong immunostaining 
from the soma to distal processes, only the cell body of neurons and not their axons or distal 
dendrites, is immunoreactive. No staining of pre- or post-synaptic profiles is observed (Han et 
al. 1994a) although ApoE has been detected at the neuromuscular junction in rodents and 
humans (Akaaboune et al. 1994). 
In the brain, 4 main ApoE receptors have been identified (Table 1). Members of the 
low-density lipoprotein (LDL) receptor family, such as the LDL receptor and the LDL 
receptor-related protein (LRP) can mediate the uptake of ApoE lipoprotein enriched particles 
into cells (Krieger & Herz 1994, Mahley 1988). In the normal human brain, granule cells of 
the DG and pyramidal neurons of other hippocampal subfields are strongly immunostained for 
the LRP receptor. Whereas astrocytes are lightly immunostained in the normal brain, activated 
astrocytes in the brain of AD patients possess a high density of LRP receptors (Rebeck et al. 
1993, Rebeck et al. 1995). In  contrast, anti-LDL antibodies weakly stain astrocytes and the 
neuropil both in normal and in AD brain (Rebeck ei al. 1993). The very low density 
lipoprotein (VLDL) receptor and the ApoE receptor 2 (ApoER2) have been localised in 
pyramidal neurons and in granule cells (Kim et al. 1996, Christie et al. 1996, Page et al. 1998). 
Recently, the presence of ApoE mRNA was demonstrated in some but not a11 neurons 
in the frontal cortex and in the hippocampus of normal controls and AD patients (Xu et al. 
1999a. Zarow & Victoroff 1998). These findings suggested that neurons are able to synthesise 
ApoE and that the reported intracellular effects of ApoE may not only be mediated by rieuronal 
upakelxit aim by in t i a~~~~~dsyn t i r i s i s  @met ai 1986, N a î h e t  al 1994, Xueîal1999a). 
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The view that ApoE can reach the cytosol via the endocytic pathway and escape 
lysosomal hydrolysis is still disputed; partly because of the reported cytosolic toxicity of 
ApoE in sonic in vimi models (DeMattos et al. 1999, Jordan et al. 1998, Moulder et al. 1999, 
Marques et al. 1997, Tolar et al. 1997). 
The levels of ApoE expression during development of the CNS are not well known 
(Elshourbagy et al. 1985). Furthermore, the role of ApoE during maturation and aging is also 
not coinpletely understood. In the CNS of wild type C57BL/6J mice, ApoE expression 
measured by iininunoblot increases with age during the period from 2 to 16 months post-natal 
(Masliah et al. 1996). Both in rodents and huinaiis, the localisation and level of expression of 
ApoE changes following brain injury or in pathological conditions as described in the 
following sections. 
1.1.3 ApoE and neuronal injury. 
Clinical studies first established a strong association between the presence of the &4 
allele and the effect of various forms of brain injury (reviewed in  (Laskowitz et al. 1998)). 
such as intracerebral haemorrhage (Alberts el al. 1995). head injury (Teasdrile et al. 1997), or 
chronic trauniatic brain injury iii boxers (Jordan et al. 1997). In all those cases, individuals 
with the c4 allele show a pooi-er prognosis for survival than those without an &4 allele. 
Following cardiopulmonary hypass surgery, patients with an &4 allele also suffer from greater 
post-operative cognitive deficits than those without an &4 allele (Newman et al. 1995). 
However, the niechanisms by which ApoE polymorphism may influence differentially the 
response and outcome to brain injury are still unclear and under investigation. Recently, some 
animal models were used to define the role of ApoE in response to brain damage. After global 
and transient ischemia injury in rodents, intraneuronal ApoE immunoreactivity is detected 6 to 
24 hours respectively after the initial insult (Horsburgh & Nicoll 1996a, Horsburgh & Nicoll 
1996b, Horsburgh et al. 1997, Kida et al. 1995). It is increased initially in astrocytes and 
neuropil, and later in ischaemic neurons (mainly CA1 pyramidal neurons in the hippocampus) 
and processes that are degenerating, probably via a ncuroiial uptake mechanism. Similar 
experiments performed on ApoE deficient mice produce increased neuronal damage compared 
to injured wild type controls, in various regions of the brain including the hippocampus (Chen 
et al. 1997, Horsburgh et al. 1999b. Laskowitz et al. 1997, Sheng et al. 1999), and suggest a 
protective role for ApoE. After focal ischemia, transgenic mice expressing the ApoE4 isoform 
have significantly larger cortical and subcortical infarct volumes compared with mice 
expressing the ApoE3 isoforin (Sheng et al. 1998). In contrast, Horsburgh et al (Horsburgh et 
al. 1999a) found no influence of ApoE genotype on hippocampal neuronal damage, or on 
ApoE neuronal and glial immunoreactivity following global ischemia in human individuals. 
However, the inability to control for the severity and length of the ischemic episode, as well as 
survival time after ischemia in human cases, may acconnt for this discrepancy. Although these 
experiments provide evidence that ApoE has a protective role after brain injury, its 
mechanisms of action are still speculative and may be plural. One favoured hypothesis seems 
to be its protective role against oxidative stress and subsequent lipid peroxidation occurring 
after glohal ischemia (Miyata & Smith 1996) its suggested by Horsburgh (Horsburgh et al. 
1999b), and Sheng (Sheng et al. 1998). This possibility is supported by the fact that plasma 
lipoproteins from ApoE KO mice are inore susceptible to in vifuo oxidation than those of wild 
type mice (Hayek et al. 1994). Moreover, the diminished recovery in ApoE KO mice after 
closed head injury is related to their inability to counteract oxidative damage (Lomnitski et al. 
1997). However, there is an alternative hypothesis for ApoE’s protective role. ApoE is 
involved in membrane remodelling as a lipid carrier after neuronal injury (PoUier et al. 1991, 
Poirier et al. 1993a), and it also exerts a neurotrophic effect on neurons in v i m  and in vivo, in 
an isoform-specific fashion (Bellosta et al. 1995, Buttini et al. 1999, Holtzinan et al. 1995, 
19 
Nathan et al. 1994). Thus, ApoE could protect against neuronal injury by exerting its effects 
on neuronal survival and/or be involved in structural neuronal repair. 
1.1.4 ApoE and entorhinal cortex lesion. 
The entorhinal cortex (EC) contributes to the major part of neural inputs to the 
hippocampus. This large supply of multimodal information is sent into the hippocampus via 
the perforant path, as described in detail in section 1.2. I .  Denervation of the dentate gyrus, due 
to loss of the perforant pathway projection from the EC, is proposed to contribute to the 
pathophysiology of AD (Geddes et al. 1985, Hyinan et al. 1984, Hyinan et al. 1986). 
Entorhinal cortex lesion (ECL) is another niodel of injury used in rodents, to examine the 
mechanisms associated with deafferentation and reinnervation. It is a classical example of 
reactive synaptogeiiesis, illustrated by the compensatory response of the hippocampus. ECL 
was shown to cause the loss of nearly 86%' of the synaptic input to the granule cells of the 
dentate gyrus (Matthews et al. 1976). A few days after denervation, new synapses are formed, 
virtually replacing the lost inputs within a few weeks (Masliah et al. 1991a, Matthews et al. 
1976). These new synapses originate from cholinergic septal neurons, glutainatergic 
comrnissural- associational hilar cells. and to a lesser extent from neurons of the contralateral 
EC (reviewed in (Deller & Frotscher 1997)). The early phase of reactive synaptogenesis and 
terminal proliferation is accoinpanied by an induction of ApoE gene expression in astrocytes 
of the deaffciented zone, a concomitant decrease in activity of the HMG-COA (3,3'- 
liydroxyiiietliylglutaryl coenzyme A) enzyme involved in cholesterol synthesis and an 
increased expression of the LDL receptor in granule cells (Poirier et al. 1991, Pouier et al. 
1993~1). Ultrastructural studies show that throughout the 2- 1 I days post-lesion, astrocytes 
progressively engulf degenerating presynaptic terminals (Lee et al. i 977). Poirier (Poirier et 
al. 1993a) suggested that non-esterified cholesterol released during terminal breakdown is 
esterified. transported via the ApoE transport system to neurons undergoing reinnervation, and 
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taken up through the LDL receptor pathway where it would presumably be used as a precursor 
molecule for the synthesis of new terminals. Abnornial nerve regeneration following ECL has 
been reported in some ApoE deficient mice (Fagan et al. 1998, Pokier et al. 1993a, Stone et al. 
1998. Teter et al. 1999a) but not in others (Anderson et al. 1998). In the latter case, other 
lipoproteins such as ApoJ may compensate foi- the loss of ApoE, as suggested by Popko’s 
results (Popko et al. 1993) after sciatic nerve crush. 
1.1.5 ApoE and structural plasticity in the nervous system. 
The first evidence that ApoE could influence neuronal structure was provided by 
Haridelniann et al (Handelinaim et al. 1992), showing that ApoE -rich ß-VLDL lipoprotein 
(used as transport vehicle capable of delivering ApoE to receptor) and cholesterol, increase 
neurite outgrowth and branching of dorsal ganglion root neurons in culture. Further studies 
using the same iiz v i m  system showed that neurons incubated with human ApoE3 and ß- 
VLDL develop long neurites. In contrast, ApoE4 combined with ß-VLDL results in the 
inhibition of neurite outgrowth (Nathan et al. 1994). Lipid-free ApoE has no effect on neurite 
ouigrowth. Similar results are obtained o n  Neiiro-2a cells (which are from a CNS derived 
neuronal cell line), when incubated with exogenous ApoE (Nathan et al. 1995), or when 
transfected to produce endogenous ApoE (Bellosta et al. 1995), boih in presence of ß-VLDL. 
To iiiduce isoforim specific effects on neurite outgrowth in thesc studies, ApoE has to associate 
with a trmïport lipoprotein veliicle directing it to the lieparan sulfate proteoglycan (HSPG)- 
LDL-receptor related protein (LRP) coniplex. Before internalisation by cells, ApoE enriched 
lipoproteins bind first to cell-surface HSPG and then to the LRP (Bellosta et al. 1995, 
Holtzman et al. 1995, Mahley 1988, Mahley et al. 1994, Sun et al. 1998). However, Neuro2a 
cell lines expressing higher levels of ApoE isoforms produce a minimally lipidated ApoE3 
isoform capable to stimulate neurite outgrowth in the absence of exogenous lipid (DeMattos et 
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al. 1998). In contrast, ApoE4 has no effect, and exogenous ß-VLDL antagonises the 
stimulatory effect of ApoE3. These results suggest that in this case, neurite outgrowth may not 
be mediated by lipid delivery and may involve other ApoE receptors than the LRP. 
Since ß-VLDL lipoproteins are not found in the CNS, further studies were carried out 
with ApoE containing HDL-like lipoprotein kom CSF or astrocyte-secreted, which are closer 
to the form of ApoE normally found in the brain (LaDu et al. 1998, Pitas et al. 1987). The 
results are similar to those obtained with cell lines (Fagan et al. 1996, Sun et al. 1998). Thus, 
when primary hippocampal neurons are grown iii presence of astrocyte monolayers derived 
firom huinan ApoE transgenic mice generatcd with the GFAP promoter, neurite outgrowth is 
greater from neurons grown in the presence of ApoE3-secreting astrocytes, compared with 
apoE4 secreting or ApoE knock-out astrocytes (Sun et al. 1998). As yet, the cascade of 
cellular events underlying the ApoE isoforrn-specific effects on neurite outgrowth is still 
unclear. However, ApoE3 stimulates the polymerisation of ß-tubulin and stabilises the 
formation of iiiicrotubules in Neuro-7-a cells, whereas ApoE4 apparently destabilises 
inicrotuhule assembly (Nathan et al. 1995, Pitas 1996). Consistent with these findings, ApoE3 
binds to microtubules and their associated proteins Tau and MAP2c in vitro whereas ApoE4 
does less (Huang et al. 1994, Nathan et al. 1995, Strittmatter et al. 1994). However, such 
interactions have not yet been demonstrated ir1 i.,iiw and it is unclear how ApoE affects 
microtiibiile formatiuri. It is well established that lipoprotein internalisation via the LDL 
receptor and the LRP is followed by an endocytic pathway that leads to lysosomal degradation 
(Krieger & Herz 1994). Although ApoE-enriched lipoproteins are also degraded by neurons, a 
portion of ApoE can apparently escape degradation as indicated by ApoE accumulation 
observed in cultured cells (Bellosta et al. 1995, Ji et al. 1998, Nathan et al. 1995). ApoE 
enriched lipoproteins can be internalised by 3 cellular mechanisms: the LDL receptor, the 
HSPG-LRP pathway, and a newly discovered HSPG-dependent/LRP-independent pathway (Ji 
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et al. 1998, Mahley 1988, Mahley et al. 1994, Weisgraher & Mahley 1996). Ji showed that this 
latter pathway is responsible for the differential retention of ApoE isoforms in the cells, and 
suggested that the ApoE4 isoform does not accumulatc because it is recycled and released at 
the cell surface (Ji et ai. 1998). These results led several authors to the following hypothesis (Ji 
et al. 1998, Lovestone et al. 1996, Mahley 6( Huang 1999, Nathan et al. 1995, Strittmatter et 
al. 1994, Weisgraber & Mahley 1996): ApoE3 may be internalised via the HSPG- 
dependent/LRP-independent pathway. escape degradation in the cytosol and complex with 
various cytosolic proteins to pwnote neurite outgrowth and microtubule stability. In contrast, 
ApoE4 inay enter a pathway that favours release from the cells, resulting in decreased 
retention and ability to modulate neurite outgrowth or remodelling. To understand how the 
ApoE isoforins can exert their differcntial effects, it will be essential to characterise the 
intracellular localisation of ApoE in detail. 
Ifi IVVO, dendritic integrity, assessed by MAP2 immunoreactivity, is preserved in the 
frontoparietal cortex and in the hippocampus of 12-month-old mice expressing the ApoE3 
isoform, compared to wild type controls. In contrast, there is extensive disruption of the 
neuronal dcndritic structure in  ApoE deficient mice aiid to a lesser extent in ApoE4 inice 
(Buttini  et al. 1999, Maslinh et al. 1995, Veinbergs et al. 1999 but see Anderson et al. 1998 for 
n o  alteration in ApoE deficient mice). Although these results require confirmation, they 
support the view that i\poE3 maintains the neuronal integrity during aging better than ApoE4. 
1.1.6 ApoE and Alzheimer’s disease 
1 .1.6.1 Alzheimer’s disease 
Alzheimer’s disease (AD) is the most coinmon cause of dementia. In industrialised 
countries, its prevalence doubles evcry 5 years after age 65 with figures in the order of 4% of 
population over age 75, up to 32% over age 90 (Evans et al. 1989). This neurodegenerative 
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disease is characterised by a progressive cognitive decline and a loss of memory. The capacity 
to recall not only recent events, but also to learn and retain new information is severely 
affected. Reasoning ability and spatial and visuo-perceptual ability are also impaired, 
accompanied by language deficits and changes in behaviour (reviewed in (Grabowski & 
Damasio 1997)). The unequivocal diagnosis of AD relies however on histopathological 
evidence at brain autopsy or biopsy. Although the histological hallmarks of AD are well 
described, establishing criteria for the niorphological diagnosis of AD is difficult because of 
the phenotypical heterogeneity of the disease, the absence of specific markers, and the overlap 
of AD pathology with changes observed in non-deinented elderly individuals. Among the 
wide variety of morphological changes described in the brain of AD patients, amyloid plaques 
and neurofibrillary pathology arc those used for the neuropathological diagnosis of AD, 
accoi-ding i» criteria based oil age-related semi quantitative assessment (reviewed in (Jellinger 
1998)). 
Aß senile plaques and neurofibrillary tangles (NFï) are considered as the pathological 
hallmarks of the disease. despite the fact that they are not specific to it (reviewed (Adams & 
Duchen 1932. Esiri & Morris 1997)). Indeed, Aß deposits without NiT occur early in life in 
Down ‘s syndrome and other conditions, while in a wriety of other disorders and normal 
aging. NFT arc present with only few or no Aß ùeposiis (Maim 1988, Simic et al. 1998, 
reviewed in (Jellingcr 1998)). 
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Senile pluques 
Senile plaques mainly contain fibrillar aggregates of ß-amyloid protein derived from 
the amyloid precursor protein (APP) (Esch et al. 1990, Sisodia et al. 1990), but also other 
proteins such as ApoE (Han et al. 1994b, Namba et al. 1991, Uchihara et al. 1995), a variety of 
proteinases (such as trypsin (Smith et al. 1993)) and proteinase inhibitors (such as a2- 
macroglobulin (Vango01 et al. 1993)). Plaques without abnormal neurites are ‘diffuse plaques’ 
whereas those surrounded by abnormal dystrophic neurites are designed as ‘neuritic plaques’ 
(Figure I ,4), The relationship between these 2 types of plaques is not entirely clear. One major 
difference is the length of Aß that is present. Diffuse plaques are Aß1-42 positive but API-40 
negative by antibody detection, whereas neuritic plaques may represent a more mature form 
and are positive for both lengths of Aß (Iwatsubo et al. 1994). Senile plaques do not occur 
naturally in the brain of aged rats or mice. However, they have been reported in aged dogs, 
bears and primates (reviewed in (Finch & Sapolsky 1999, Walker 1991)). Infiltration of 
cerebral artery walls by ß- amyloid is present in virtually all cases of AD and described as 
amyloid angiopathy (Glriiiicr & Wong 1981). 
Neiir.ofihrilla ptithologj 
The 3 fornx of neurofibrillary pathology include the neurofibrillary tangles (NIT), the 
dystrophic neurites of neuritic plaques and the neuropil threads (NT) which are found 
scattered in the neuropil (reviewed in (Esii-i & Morris 1997, Terry et al. 1994)). All represent 
accumulations of insoluble paired helical filaments (PHF) which are composed of abnormally 
hyperphosphorylated microtubule associated Tau protein (Goedert 1993). In pyramidal 
neurons, N F ï s  accumulate in the cytoplasm in a flame shape and displace the nucleus (Figure 
1.4). The PHFs are so insoluble that they remain within the neuropil as ghost tangles after the 
death and degeneration of the cell in which they developed. They become coated with other 
molecules such its GFAP, ubiquitiii and ApoE (Yamaguchi et al. 1994). 
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Other lesions 
Hiraiio bodies and granulovacuolar degeneration are 2 other features of AD pathology 
that have been described but not well understood (see review by (Anderton 1997, Esiri & 
Morris 1997, Terry et al. 1994)). To complete the pathological picture of AD, there is a 
striking loss of neurons and synapses associated with cortical atrophy. 
Neuronrrl loss 
Whereas in normal human aging only neurons from the dentate hilus and from the 
subiculum die. numbers of CA I hippocampal cells and neurons from layers Il  and IV of the 
entorhinal cortex (EC) are severely diminished in AD (Davies et al. 1992, Gomez Isla et al. 
1996, Hyinan et al. 1984, Morrison & Hof 1997, West et al. 1994b). At the subcortical level, 
the cholinergic basal nuclcus of Meynert and diagonal band of Broca also lose neurons, in 
parallel with reduced concentrations of acetylcholine (ACh) and acetylcholinesterase (AChE) 
activity in their projections zones, the hippocampus and the cortex (Davies & Maloney 1976, 
Perry et al. 1977. Whitehouse et al. 1982). The synthesis of ACh is assured by reaction of the 
choline acetyl transferase (ChAT) with choline. However, concentrations of choline and the 
activity of ChAT are greatly diminished in the brain of AD patients (Nitsch et al. 1992, 
Whitehouse et al. 1982). Moreover. cholesterol, which is required for the proper functioning 
of nicotinic receptor subtype is also reduced in the brain AD patients (Jones et al. 1988). The 
ACIiE inhibitor Tacrine was designed to take advantage of the residual cholinergic activity 
and provided temporary cognitive improvement in some AD patients but not all (Pokier et al. 
1995, Poirier & Sevigny 1998). 
Sj~nuptic loss 
One major hallmark of AD is the massive loss of synapses. The molecular layer of the 
DG of the hippocampal formation is one of the regions most affected, and at a very early stage 
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of the disease. Reported synaptic decreases vary from 20 to 65% compared to aged-matched 
controls, depending on methods of assessment (electron or light microscopy) and severity of 
disease (Cabalka et al. 1992, Heinonen et al. 1995b, Masliah et al. 1994b, Sze et al. 1997). 
Other hippocampal fields and neocortical regions are also affected, but later in the disease 
process. Regions include the frontal cortex and temporal cortices, the nucleus basalis of 
Meynert and the locus ceorulctis (Hainos et al. 1989, Honer et al. 1992a, Lassman et al. 1992, 
Lippa et al. 1992, Masliah et al. 1991~) .  
Several pathological changes occtir at the synaptic site. At the ultrastructural level, 
most presynaptic terminals contain abnormally enlarged clear and dense-core vesicles. Others 
are dilated and contain increased numbers of normal-size vesicles, with occasional electron- 
dense bodies. In contrast, other presynaptic terminals show moderate to severe loss of 
presynaptic vesicles (Gonatas et al. 1967, Masliah et al. 1991b). Most presynaptic proteins 
such as Synaptophysin, Synapsin I and Rab3 for example, are severely and concomitantly 
depleted (Hamos et al. 1989, Heinonen et al. 1995b, Honer et al. 1992a, Lassman et al. 1992, 
M, ‘I5liah . ’ et al. 1991b, Masliah et al. 1994b, Sze et al. 1997). Studies assessing synaptic loss by 
stereological counting have also established that synaptic loss is accoinpanied by an increase 
in mean synaptic size. This phenomenon has been observed in the frontal and temporal 
coitices as well as in the inner and outer molecular layer of the DG (DeKosky & Scheff 1990, 
Sclieff & Price 1993, Scheff et al. 1996, Scheff & Price 1998), and is interpreted as a 
compensatory response to rnaintain a certain level of synaptic area, and therefore of synaptic 
transmission. 
A trophy 
Concomitantly with synaptic and neuronal loss, various regions of the brain are 
affected by atrophy during AD. Both white and grey matters are involved (Mann 1991). The 
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volumes of the hippocampus, the amygdala and the temporal lobe are significantly altered (De 
Toledo Morre11 et al. 1997, Geroldi et al. 1999, Jack et al. 1992, Lehtovirta et al. 1995, Mann 
1991, Yasuda et al. 1998). A detailed review is provided in section 3.2. 
Neiir-u~>citholofiicul corre1crie.y of demeniin n i i d  hypotlietical uetiology of AD 
Although the picture of AD pathology is now very detailed, the aetiology of the 
disease is still unclear and several questions remain unanswered. What triggers the formation 
of senile plaques and of NFT? What is the mechanism of neuron death and synaptic loss? Are 
there relevant cause/effect relationships between all those features'! Which lesions ai-e 
responsible for memory and cognitive deficits? And ultimately. can we reverse the disease 
process? All these questions have been under intense scrutiny for the last decade but only 
partial answers have been obtained. In  order to slow 01- prevent the disease, it is essential to 
identify the steps where pathogenesis could be inhibited. 
The sequence of neurofibrillary pathology is predictable and shows little variation 
between AD patients. It can be divided into 6 stages, beginning with invasion of the 
transerithorliinal cortex to finally affect other portions of the cerebral cortex and subcortical 
nuclei. The Braak staging system is based ou location of damaged neurons and on the severity 
of changes (Braak & Braak 1991, Braak & Braak 1998). In general, initial NFT stages I and I1 
develop in the transentorhinal cortex in the absence of Aß deposits and of clinical symptoms. 
The linibic stages 111 and IV show progression of neuritic lesions from the parahippocampal 
region to the hippocampus with preservation of the neocortex. The terminal stages V and VI 
represent fully developed AD with widespread devastation of the neocortex. Primary motor 
and sensory areas are the last to he affected. At that stage, patients are severely demented. 
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The question of whether plaques or tangles appear first, remains a indtter of intense 
debate. According to Bra& (Braak & Braak 1991), N F ï s  and NTs generally precede the 
forination of ß-amyloid deposits in some coinponents of the hippocampal formation 
(prosuhiculum and CAI)  and in the entoi-hinal region, whereas in others (DG and subiculum) 
ß-amyloid usually appears before the formation of the neurofibrillary changes. Neocortical 
areas show accumulation of ß-amyloid before the first appearance of N F ï s  and NTs. Size and 
shape of the deposits and their distribution pattern vary from one individual to another and are 
unrelated to age (Braak & Braak 1991, Fewster et ai. 1991. Morris 1997). However, all 
investigators do not share this view. Some found that at very early stages of AD. patients have 
a pattern of taiigle formation identical to that of non-demented aging. Although they occur in 
slightly greater densities in AD, individual variation and overlap exist, thus the differences 
may not be diagnostic (Morris et al. 1991, Morris et al. 1996b, Morris 1997, Price et al. 1991. 
Price 1993). In  contrast, truly non-demented aging is associated with few. if any neuritic or 
diffuse plaques, whereas even in the earliest clinically detectable stages of AD, neocortical 
plaques are already promiiient. This suggehts that lhe pi-csence o f  rieocoitical plaques, and 
particularly those with neuritic changes, hest represent the disease process of AD. The 
possibiliky thai a few NETS or plaque\ i n  non-demented elderly could represent a preclinical 
stage of the disease rdthei- than normal aging is still  inr resolved. Additional confusion is 
provided by the results of correlation studies. Several authors have correlated the severity of 
dementia with various neuropathological measurements such as plaque number, amyloid lond. 
NFT number, synapse loss or hippocampal volume. and have inferred that oiie particular 
feature is more relevant to the pathology than the others (Arriagada et al. 1992, Bobinski et al. 
199521, Bobinski et al. 1995h. Cuminings et al. 1996, DcKosky & Scheff 1990, Dickson et al. 
1995, Hyman et al. 1986, Nagy et al. 1995b. Nagy et al. 1996, Samuel et al. 1994. Sze et al. 
1997, Terry et al. 1991). Synaptic loss in various cortical regions and in the hippocampus is 
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generally accepted as the hest correlate of dementia severity. However, this observation says 
little about disease pathogenesis. There are indications that the presence of N F T s  is associated 
with synaptic loss (Callahan & Coleman 1995; Honer et al. 19921, Lassman et al. 1992) while 
synaptic loss is no greater within diffuse plaques than in the neuropil outside them (Heinonen 
et al. 1995h, Masliah et al. 1990, Masliah et al. 199ih). However, it is severely accentuated 
within mature plaques (Masliah et al. 1990). Because synaptic loss is an early event in AD 
(particularly in the molecular layer of the DG) (Hcinoiien et al. 1995b, Hyman et al. 1986. 
Masliah et al. 1994b), Masliah suggested that the pathogenic process of AD begins with 
synaptic loss and neurodegeneration rather than with deposition of Aß protein (Martin et al. 
1994' Masliah et al. 1991h. Masliah & Terry 1993, Masliah et al. 1993, Masliah et al. 1994a, 
Masliah 1995, Masliah 1998). In support of this theory, APP is normally present in synapses 
where it inn); play a role in synaptic stahilisation and neuroprotection, whereas in AD, APP 
abnormally accumulates in the plaque dystrophic iieurites and in synaptic terminals (Maslinh 
1998). Neui-odegeneration might follow via several hypothetical mechanisms, including I )  
direct toxicity of one of its degradation products, Aß, 2) disruption of synaptic function or 3 )  
deficient glutamaie trnnspoitcr activity resulting in glutamate neurotoxicity. Although there is 
evidence wppoiting this new theory, it i> I ~ O L  generally accepted. 
Thc discrepancies between results in the quest for the besi correlate of dementia could 
arise ihrougli a number of possibilities: the variety of inorphometric techniques used, how they 
are applied. which regions of the brain are studied, and the stage at which the disease is 
examined. Controversy niay also originate froin the phenotypic and genetic heterogeneity of 
the disease. Since the early 1990s. it  has been shown that some forms of AD are associated 
with the inheritance of mutant genes, including those which encode the amyloid precursor 
protein (APP), and presenilin 1 and 2 (PSI and PS2), or with the presence of specific alleles of 
apolipoprotein E (ApoE) (Chartierharlin et al. 1991, Corder et al. 1993, Goate et al. 1991, 
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Levylahad et al. 1995. Roses et al. 1994, Sherrington et al. 1995). Mutant APP, PSI and PS2 
are linked to relatively early cases of autosomal dominant familial AD (FAD) and are 
considered as causative genes whereas ApoE acts as a susceptibility gene, with the &4 allele 
increasing the risk of AD in a dose-dependent fashion in cases of late-onset AD (reviewed in 
(Esiri & Morris 1997, Wasco & Tanzi 1995)). Although AD is genetically heterogeneous, 
there is little or no difference in either the symptoms of dementia or in the pathology of the 
lesions in the brains of patients affected with the various types of AD (Lippa et al. 1996, 
Wasco & Tanzi 1995). Whilst this suggests that a common pathological mechanism may be 
involved, there is no reason to suspect that all the forms of AD, inherited 01- not, have 
necessarily identical pathogenic routes to similar neuropathology. 
Despite the low propoition of familial AD caused by gene mutations, their biological 
significance is important because they all result in an increased production of Aßl-42, which 
is the main component of amyloid deposition (reviewed in (Hardy 1997, Neve & Rohakis 
1998. Wasco & Tanzi 1995)). This finding, added to the fact that Down's syndrome patients 
develop the pathology of AD, and possess an additional chi-oriiosome 21 where the APP gene 
is located, pointed to a role of Aß in AD pathology. This gave rise the amyloid cascade 
hypothesis as a possible pathological mechanism (Selkoe 1997). Although it is inappropriate 
here to devclop fully the arguments in favour or against this theory (reviewed in (Hardy 1997, 
Neve & Robakis 1998, Wasco &i Tanzi 1995)), it is important to describe briefly its main 
concept, since other factors such as ApoE may he involved, as explained in the following 
section. Selkoe (Selkoe 1997) summarised the theory as fol1ows:"all gene defects lead to 
enhanced production, increased aggregation, or perhaps decreased clearance of Aß peptides. 
Aß 1-42, which is highly self-aggregating, would then accumulate, followed by Aß 1-40. The 
gradual cerebral build-up of Aß appears to result in local inicroglial and astrocytic activation, 
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with concomitant release of cytokines and acute phase proteins. These inflammatory changes 
or the direct toxicity of Aß would injure local neurons and their processes, causing profound 
metabolic changes. These could include altered Tau phosphorylation and PHF formation in 
some plaque-associated neurites and in neurons containing NFïc .  Neuronal and glial injury 
would result in synaptic and neuronal loss, accompanied by several neurotransmitter deficits.” 
Although there is little doubt that Aß plays a major role in the pathology of AD, 
several authors have challenged the idea that it is the primary cause of AD neurodegeneration. 
These issues have been reviewed i n  detail elsewhere by several authors (Esiri & Morris 1997, 
Hardy 1997, Neve & Robakis 1998). One major criticism is thc lack of consensus regarding 
the mechanism by which Aß destroys neurons (Neve & Robakis 1998). and the observation 
that all but one transgenic models of Aß deposition failed to detect neuronal loss (Calhoun et 
al. 1998b, Duff 1998, Price et al. 1998). In  addition, hi-ains of some non-demented individuals 
also contains diffuse Aß deposits, ;ind the total number of Aß deposits shows only a modest 
cori-elation with dementia (Arriagada et al. 1992, Gomez isla et ai. 1997. Nagy et al. 1995b). 
How Aß deposit ion could lexl io neurofibrillary pathology is also unclear. 
The present section is by no means a comprehensive review of AD pathology and lines 
of research. Several detailed books and reviews are available on the subject (Anderton 1997, 
Esiri & Morris 1997, Tei-ry et al. 1993). This brief introduction of AD is however necessary to 
‘set the stage’ for the following section dealing with the role of ApoE as a risk factor for AD. 
Indeed, although gene mutations provide an invaluable basis for research, they are responsible 
for only a very low proportion of AD eases. For example, mutations of the APP gene account 
for approximately 7% of early onset AD cases, which in turn represent only 15% of all AD 
cases (Wasco & Tanzi 1995). In contrast, the most common genetic predisposition for late AD 
is conferred by inheritance of the ~4 allele of the apolipoprotein E gene. The following section 
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examines the evidence in  favour of a role of ApoE in AD pathogenesis, and how it may 
feature in the current hypothetical mechanisms of the pathology. 
1 .I .6.2 Possession of ~4 is a risk factor of AD 
In 1993, Allen Roses and his colleagues at Duke University demonstrated a 3-fold 
excess of the &4 allele for AD patients aged 65+ with (Corder et al. 1993) and without 
(Saunders et al. 1993b) close rclatives also affected with AD. They showed that the risk of 
developing sporudic and late-onset familial Alzheimer’s disease increases, and the age of 
onset decreases with the number of inherited &4 alleles (Figure 1.5). This association has since 
been confirmed worldwide, although the €4 allele frequency varies in different ethnic 
populations. Further investigation demonstrated a protective effect of the &2 allele for familial 
and sporadic AD (Corder et al. 1994, Lippa et al. 1997. Talbot et ai. 1994, West et al. 1994a). 
Survival froni the onset of the symptoms of AD and the rate of progression of the 
disease are not influenced by ApoE polymorphism suggesting that the preclinical &related 
processe5 do not continue during the clinical disease and do noi cause nioi’e rapid decline 
among &4 carriers (Corder et al. 1993, Corder et al. 1994, Corder et al. 1995a, Hyman et al. 
19961) but see Frisoni et al. 1995, Ohrnet al. 1999, Stern et al. 1997). 
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Figure 1.5 Risk of' renzaiiziiig uiiuffected by A D  (late onset) in relation to ApoE genotype. 
From Corder et u1 1998. 
However, the mechanisms by which ApoE isoforins are involved in the pathogenesis 
of AD are not yet elucidated. The finding that ApoE is detected in the characteristic lesions 
associated with this pathology, i.e. in extracellular smile plaques. intraneuronal fibrillary 
tangles and ß-aiiiyloid containing blood vessels (Namba et al. 1991, Reheck et al. 1993, 
Schmechel et al. 1993. Strittmatter et al. 1993a. Wisniewski & Frangione 1992) opened new 
perspectives about the involvement of ApoE in AD, and an increasing number of studies now 
focus on the interactions of ApoE isoforins with key molecules of AD pathology. Thus, 
examining possible correlations between possession of the &4 allele and the number, size or 
degree of severity of the key lesions of AD has been a common approach. In fact, with the 
emergence of the amyloid cascade hypothesis, interest has been focused largely on association 
between the &4 allele and Aß deposition 
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ApoE and A ß  deposition 
Several investigators demonstrated that brains fiom ~4 AD patients contain 
significantly more amyloid plaques compared to &3 patients (Beffert et al. 1999, Hyman et al. 
1995, Ishii et al. 1997, McNamara et al. 1998, Mann et al. 1997, Nagy et al. 1995a, Ohm et al. 
1995, Oyama et al. 1995, Rebeck et al. 1993, Schrnechel et al. 1993) with a clear gene dose 
effect, so that plaque density correlates positively with the number of ~4 alleles. In contrast, 
other groups failed to demonstrate such a correlation, some suggesting that differences in 
ethnic populations, stages of pathology and technical considerations may be responsible for 
these discrepancies (Berg et al. 1998. Landen et al. 1996, Pirttila et al. 1997). I?, virro studies 
have revealed inultiple and coinplex relationships between Aß and the different ApoE 
isoforms. ApoE3 protects cultured cells from Aß-induced neurotoxicity, whereas ApoE4 does 
less (Miyata & Sinith 1996), does not (Jordan et al. 1998) or even increases neurotoxicity (Ma 
et al. 1996). ApoE4 is more efficient than ApoE3 in promoting amyloid fibril formation 
(Castano et al. 1995, Ma et al. 1994. Strittmatter et al. 1993b). ApoE2 and E3 promote the 
binding and uptake of Aßl-40 into chinese hamster ovary cells better than ApoE4 (Yang et al. 
1999). while in hippocampal neurons, ApoE4 increases Aßl-40 uptake (Beffert et al. 1998,) 
more than ApoE3. Conversely, Aßl-40, API-42 and Aß2S-35 increase the binding of ApoE4- 
liposomes more than that of ApoE3 (Beffei-i et al. 1998a). [ri i,ivo, APP overexpresser mice 
crossed with ApoE deficient nice (APP+/-, ApoE-/-) forin Aß deposits much later than APP 
overexpresser niice with normal ApoE levels (Bales et al. 1997), suggesting that ApoE 
influences Aß deposition in vivo. The same APP+/-, ApoE-/- inice crossed with ApoE3 or 
ApoE4 transgenic mice (whose astrocytes express physiological concentrations of human 
ApoE in the absence of mouse ApoE) dramatically suppress early Aß deposition in vivo, in 
contrast to the effect of mouse ApoE, or even when compared to mice lacking ApoE 
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(Holtzman et al. 1999). It is unclear why in this model, human and mouse ApoE produce 
opposite effects on Aß deposition. The authors suggested that each type of ApoE may have 
contrasting properties regarding Aß fibrillogenesis, or that human ApoE may promote Aß 
clearance better than mouse ApoE. 
ApoE cuid NFT 
Studies on the association of the &4 allele with NFT, the other major lesion of AD, 
have produced contradictory data. Initial reports indicated that the number of N F ï s  is greater 
in individuals with the ~4 allele than in those without (Beffert & Poirier 1996, Nagy er al. 
199%. Ohm et al. 1995) but such a correlation was not found by others (Berr et al. 1994, 
Gomez Isla et al. 1997, Landen et al. 1996, Landen et al. 1996, Morris et al. 1996a, 
Mukaetova-Ladinska et al. 1997, Oyama et al. 1995). In young individuals with initial 
neurofibrillai-y changes (Braak’stage I), the hequency of the &3 allele is higher than in aged 
matched conti-01s devoid of such changes (Ghebreinedhin et al. 199X). Consistently, in normal 
individuals and AD patients, the &4 allele is associated witli a higher stage of neurofibrillary 
formation compared to aged-indtched &3 patients (Ohm et al. 1999). This suggests that the &4 
allele not only influences the agc of onset of the disease, but also possibly contributes to the 
formation of initial neurofibrillary changes at a young age. The molccular mechanisms behind 
the association of the ~4 ¿illele and the formation of NFT are still unknown. Zri vitro, ApoE3 
interacts with Tau whereas ApoE4 does not, suggesting that ApoE3 may prevent Tau 
phosphorylation, and allow it to function normally in microtubules. In the presence of ApoE4, 
Tau would not be protected from hyper-phosphorylation, becoming inactive and forming 
NFTs (Lovestone et al. 1996, Strittmatter et al. 1994). However, it is debatable whether ApoE 
can interact with Tau or tubulin from within the cytosol because I )  ApoE is a lipid-binding 
protein and it is unclear how it could exist in a lipid-free form in the cytoplasm, and 2) ApoE 
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would have to escape lysosomal degradation after internalisation if it was exogenous to the 
neuron. 
A p E  c=rl>ression i i i  AD 
The cellular localisation of ApoE is indeed crucial to understand its involvement in the 
pathology of AD. It is still unclear whether the degree of  neuronal ApoE transcription and 
expression differs between normal non-demented controls and AD patients (Diedrich et al. 
1991. Oyama et al. 1995, Yamada et al. 1995, Zarow & Victoroff 1998). ApoE expression 
level in &4 AD patients is either reduced (Bertrand et al. 1995, Yamada et al. 1995, Beffert, 
1999) or not different froin that of iion-&4 carriers (Han et al. 1994a, Hesse et al. 1999). ApoE 
is present not only in NFT's, but also in the vulnerable neurons that do not hear NFTs, in the 
brain of AD, Parkinson's disease patients and in non-demented aged controls (Han et al. 
1994b). A recent study showed that in 3 visual cortical areas (Einstein et al. 1998), the 
disiribution of intraneuronal ApoE paralleled the regional distribution of pathological changes 
that occur during AD. The presence of intraneuronal ApoE ai the earliest Braak and Braak 
stages (Braak & Braak 199 I )  in non-deiiientrd conir«l brains suggested that ii could represent 
a normal characteristic of neocoilical neurons, or be a sign of neuronal challenge or iiijury, 
marking preclinical AD. The fact that the cerebelluin (which is a relatively spared structure in 
AD coiiipai-ed with cerebral cortex) displays a very strong ApoE transcription in glial cells hut 
uone in neurons. indicates that ApoE gene expression in  neurons niay be one factor or marker 
for selective vulnerability of cerebral cortical neurons observed in AD. The significance of 
ApoE accumulation in injured neurons reinains to be determined. I t  may represent an initial 
protective response to injury by providing cholesterol and lipids for neuronal repair. 
In addition to its presence in different categories of  cells, ApoE is also bund in the 
cerebrospinal fluid (CSF) associated with lipoproteins and it is produced within the blood- 
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brain-barrier (Linton et al. 1991, Pitas et al. 1987). As yet, there is no agreement about the 
levels of CSF ApoE in AD. Some authors have reported no change (Lefranc et al. 1996) or a 
decrease (Blennow et al. 1994. Lehtimaki et al. 1995) associated with AD, suggesting that this 
measurement inay not be useful for the diagnosis of Alzheiiner pathology. 
ApoE, cliolirie~gic ílysf~i~~cii~~~~ and treutineiit ($AD 
The cholinergic system is severely affected by AD. Moreover, the maintenance of this 
system relies heavily on lipid delivery to synthesise ACh (Nitsch et al. 1992). This suggested 
that the role of ApoE in lipid transport could be central to the pathology in &4 AD patients. 
ApoE associates with lipoproteins transpoiting essential lipids for the ACh system (LaDu et al. 
1998, Fagan et al. 1999). Amongst them are phosphatidylcholine (PC) and 
phosphatidylethanolainine (PE). These brain membrane phospholipids, are both donors of 
choline, which itself is a rate-liiniting precursor of Ach. Cholesterol, which is required for the 
proper functioning of nicotinic receptor subtypes (Jones et al. 1988), is also transpoited via 
ApoE- enriched lipoproteins (Mahley 1988). It is interesting that &4 AD patients have reduced 
levels of PC and PE, as well as iiicreaïed levels or products froin their breakdown in the hraiii 
(Klunk 1998). In addition, &4 AD palients show a reduced activity of enzyme responsible for 
the synthesis of Ach, ChAT, reduced nicotinic receptor binding sites coinpai-ed to non-&4 
carriers (Arendt et al. 1997, Pokier et al. 1995 but see Svensson et al. 1997). and reduced 
iiuinber of cholinergic neurons iii the nucleus basalis of Meynert (Arendt et al. 1997, Pokier et 
al. 1995 but see Salehi et al. 1998). This general degradation of the cholinergic system inay be 
due to impaired lipid delivery in &4 carriers, resulting in either degradation of membrane afiei- 
use of their PC to synthesise Ach, or in the contrary, shut-down of ACh synthesis and 
cholinergic neurotransmission to preserve membrane integrity and plasticity (Beffert et al. 
1998b, Pokier 1994, Pokier et al. 1995). ApoE deficient nice have dccreased PC levels and 
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display abnormal cholesterol distribution in brain membranes preparations (Igbavboa et al. 
1997, Lomnitski et al. 1999). In addition, most ApoE deficient mice failed to detect any 
significant alteration, as assessed by ChAT activity, ACh release, nicotinic and muscarinic 
receptor binding sites and AchE staining (Anderson & Higgins 1997, Fagan et al. 1998, 
Krzywkowski et al. 1999, Parker et al. 1996, but see Chapman & Michaelson 1998, Gordon et 
al. 199621). Taken together, these findings favour the hypothesis that a compensatory 
mechanism may alter membrane lipid composition to maintain the integrity of the cholinergic 
system. 
According to the hypothcsis that &4 AD patients have an impaired cholinergic system, 
cholinergic drug therapies, such as Tacrine, which are based on the functional use of residual 
cholinergic functions, are expected to be moi-e efficient in noii-&4 carriers. However, such an 
effect is still unclear (Poirier et al. 1995, Poirier & Sevigny 1998, Mac Gowan et al. 1998). 
Taken together, these findings suggest a number of ways in which ApoE 
polymorphism could influence the severity of AD pathology. Figure 1.6 illustrates ApoE 
interactions with the various components of this neuropathology. 
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1.2 ApoE and cognitive impairment. 
This section first examines how morphological parameters could account for memory 
and cognitive deficits observed during aging and the pathology of AD, and then reviews the 
current findings linking ApoE polymorphism to cognitive impairment. 
1.2.1 Morphological correlates of cognitive impairment. 
AD, and often aging too, are accompanied by deficits in learning and memory in 
humans and animais. Attempts to define the neurobiological substrates of memory dysfunction 
have led to the precise description of morphological changes that occur in the brain during AD 
and aging. An important feature of memory impairment in both cases is the selective 
vulnerability of new information. In contrast, the capacity to recall information acquired in the 
distant past is preserved (Rempel Clower et al. 1996, Teng & Squire 1999). This deficit is 
similar to that attributed to bilateral hippocampal damage in man. 
Attention to the mnemonic functions of the temporal lobe was raised by the human 
case HM. After bilateral surgical removal of the medial temporal lobe, HM suffered from 
severe anterograde amnesia (Scoville & Milner 1957). Since then, several cases of human 
amnesia have confirmed and extended the findings with monkeys and rodents. They show that 
bilateral damage limited to the CA1 region of the hippocampus is sufficient to produce 
moderately severe anterograde memory impairment, and that bilateral damage to the 
hippocampal formation beyond the CAI region can produce even more severe anterograde as 
well as retrograde amnesia covering up to 15 years (Squire & Zola 1996). In rodents, 
electrophysiological recordings, and selective lesions of the hippocampus disrupting the 
acquisition of spatial tasks, indicate that the dorsal hippocampus but not its ventral part plays a 
special role in spatial learning (Bontempi et al. 1999, Hampson et al. 1999, Moser & Moser 
1998, Wood et al. 1999). In parallel with lesion studies, functional imaging in normal human 
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brain have confirmed the importance of the hippocampus for other fo rm of memory, by 
demonstrating hippocampal activation during the encoding of verbal and visual inîormation 
(Fcrnandez et al. 1999, Rempel Clower et al. 1996, Squire tk Zoia 1996, Teng & Squire 1999). 
In AD, the neuroanatomical distribution of lesions makes it clear that the liippocainpus 
is functionally disconnected from the cerebral cortex early in the disease (Hyman et al. 1984). 
Before expanding ou this subject, it  will be helpful to introduce briefly the anatomy of the 
hippocampus. Figure 1.7 describes the intrinsic and extrinsic connectivity of the hippocampus. 
Thc entorhinal cortex is the only cortical region 10 project to the hippocampus. The cell bodies 
of its layers 11 aiid 111 send their axons to the outer two thirds of the molecular layer of the DG, 
forming the perforant path (PP) and making synapses with the dendritic branches of the 
granule cells of the DG. The DG projects in turn to the cells of the CA3 region, which connect 
pyramidal cells of the CA1 region. Outputs from CAI neurons reach several subcortical and 
cortical regions, including the subiculum aiid thc amygdala. Examination of teinporal lobe 
structures from Aû patients show that cells from layers I l  and IV of the EC as  well as CAI 
and subicular neurons are affected by NFT and senile plaques early in AD pathology (ßraak & 
Braak 199 I ,  Hyman et al. 1986). By disrupting cortico-hippocanipal and hippocainpo-cortical 
connections, AD pathology functionally isolates the hippocainpus from the cortex, leading to 
the early signs of inciiiory impairment. Consistently, the molecular layer of the DG is one of 
the regions iiiost affected by synaptic loss, probably as the i-esult of neuronal death of the EC 
cells (Cabalka et al. 1992, Heinonen et al. 1995b, Masliah et al. 1994b. Sze et al. 1997). 
Again, this event occurs very early in the disease and has been strongly correlated with 
memory impairment (DeKosky & Scheff 1990, Samuel et al. 1994, Sze et al. 1997, Terry et al. 
1991). Whilst the rationale for early nieinory impairment in AD seems apparent in Iiuinans, 
this is not the case for age-related cognitive impairinent in non-huinan aniinals which do not 
develop AD nor its lesions. 
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To date, a wide variety of mammals including monkeys, polar bears arid dogs. 
naturally develop Aß deposition with neurocytoskeletal abnormalities but no evidence of N I T  
(Finch & Sapolcky 1999, Walker 1991). However, laboratory rodents are the cxception and do 
not develop such pathology. Several species show cognitive deficits at an old age. In the aged 
dog, cognitive dysfunction correlates with Aß accumulation (Cumnings et al. 1996) whereas 
in nioiikeys, it correlates better with myelin breakdown and loss of white matter (reviewed in 
Peters et al. 1996). However, as in humans, there are individual differences, and some 
monkeys or rats show more impairinent than some others at the saine age. Those which show 
the least impairment can be regarded as aging ‘successfiilly’ (Rapp & Amaral 1992). Amongst 
the aniinal models developed to study the neurobiology of aging, rodents offer a relativcly 
short life span, sinall size and high fertility. A number of behavioural tasks can test inernory 
and cogiiitivc performance. Spatial navigation tasks in various mazes are conunonly used to 
detect decline in spatial memory, which is particularly vulnerable with advanced age and is 
sensitive to hippocampal damage (Ingram & Jucker 1999, Mac Donald & Overmier 1998. 
Squire & Zola 1996). 
Because the neuron is the basic functional unit of the brain, several investigators have 
counted neuronal numbers in specific brain regions known to bc involved in cognitive deficits 
associated with aging arid AD. such ab the hippocampus. A coininon hypothesis is that specific 
iieui-oiial loss may be reSpCmibk for cognitive alterations. Such belief was suppor-ted by early 
huinan studies showing a negative correlation between age arid neuronal density in the 
neocortex, indicating up io 40% neuronal loss during aging (Brody 1955). This view has since 
been seriously challenged because of technical issues. Haug (Haug et al. 1984) established that 
preparation of brain tissue Tor microscopy causes young cortical matter to shrink inore than 
aged tissue, and therefore considerably biased measurenieiits of neuronal density. Moreover. 
appropriate stereological methods for neuron quantitatioii have been unavailable until recently. 
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making earlier data questionable. Nowadays, changes in neuronal number are assessed with 
unbiased stereological tools. It is now clear that in aged humans, neuronal loss is limited to 
specific brain regions only. There is no substantial loss of the principal neurons of the 
hippocampus (Davies et al. 1992) and in the EC (Gomez Isla et al. 1996, Morrison & Hof 
1997) bui a decrease of neuron numbers in subiculum and the hilus of the DG (West 1993). 
This pattern is clearly different from that of AD, where neuronal loss severely affects the CAI 
region of the hippocampus and layers I1 and IV of the EC (Hyman et al. 1984, Hyman et al. 
1986, West et al. 1994b). 
Recent studies have evaluated the relationship between the ability of aged rats to learn 
a hippocampus-dependent task such as the Morris water maze task, and the number of 
principal hippocampal neurons. For each of the hippocampal fields, neuron number was 
preserved in aged rats us a group and in aged individuals with spatial learning deficits, in 
comparison with young rats (Rapp & Gallagher 1996, Rasmnssen et al. 1996). Thus a loss of 
principal neurons does not occur in the hippocampus of old rats and cannot account for agc- 
related deficits in hippocainpus-dependent learning and memory. In C57BL/6 mice, there is 
also no loss o!' neurons in CA1 or in DG and there is no age-related deficit for the Morris 
water maze task (Calhoun et ai. 1998a). 
Other candidates as a substrate for learning mid memory deficits are changes in 
synapse number and in synaptic efficacy. There is a growing body of evidence that memory 
processes are mediated by structural changes in synapses as well as enhancement of synaptic 
strength (Bailey & Kandel 1993, Doubell & Stewart 1993, Hunter & Stewart 1993, Patel & 
Stewart 1988, Rusakov et al. 1993, Rusakov et al. 1995, Rusakov et al. 1997, Stewart & 
Rusakov 1995, Stewait el al. 1998). However, estimation of synaptic densities in several brain 
regions and in different species have produced inconclusive data (see Table 2). Again, only 
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recently developed stereological tools provide reliable data and studies using these techniques 
are still in a minority. Attempts to correlate cognitive status with synapse density ai-e also rare. 
Cognitive and learning abilities in mice can be affected by aging and mouse strains (Jucker & 
Ingram 1997, Owen et al. 1997. Roullet & Lassalle 1995). C57BL/6 mice are commonly 
preferred for the production of transgenic mice. Both their perfoi-mance in the water maze and 
the number of synaptophysin positive boutons in the ML of the D G  or in CA1 are largely 
preserved during aging (Calhoun et al. 1998a, Ingram & Jucker 1999). Moreover, there is a 
positive correlation between water maze performance and number of DG synapiophysin- 
positive boutons. Rats and monkeys show age-related cognitive decline, however they only 
display ininor or regionally specific synaptic lo These observations first suggested that 
synaptic loss inay not underlie cognitive decline. However, many technical issues need to be 
raised. Very few studies have used stereological methods to count synapses and few 
hippocampal sub-fields have been examined. Moreover, when synaptic proteins Icvels were 
measured, often the whole hippocainpus was dissected. The absence of a correlation between 
protein levels and perfoi-mance at specific learning a n d  cognitive tasks inay be due t u  the fact 
that functional specificities of the hippocampal sub-regions, as well as the functional 
distinction between dorsal and ventral hippocampus, were not taken into account. 
Ultrastructural studies provide the most dcfinitivc assessment of synaptic structural changes, 
however they do not detect alterations in the specific syiiaptic or  receptor proteins which lead 
io chiiiiges in functional connections. For example, Barnes' physiological studies in aged ruts 
have shown that a decrease in synaptic input (consistent with synaptic loss) to the D G  from the 
EC is accompanied by an increase in the strength of existing connections (Barnes 1994. 
Barnes 1999). Finally, the relationship between synaptic strength and levels of synaptic 
proteins is unknown. Therefore, studies using levels of synaptic markers as an  index of 
synaptic connectivity are difficult to interpret. 
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Investigators 
1Nicollrrtnl. I B Y I  
Calhou" et ill 1998a) 
Method for 
synapse 
quantification 
EM 
EM 
EM 
EM + siereology 
EM + stereology 
ELISA/ 
Synaptophysin 
Inimunoblot 
Syiiaptophysiiil 
Synaptotagniini 
SNAP25 
Counting 
S ynaptophysin 
iminunolahelled 
boutoiis 
Counting 
Synaptophyain 
immunolahelled 
houtoiis 
Species 
rat 
nouse 
Brain regions investigated 
MML of DG 
IML of DG 
IML of DG 
IML and MML of DG 
CA3 
Entorhinal cortex hippocainpus and 
other regions 
Hippocampus 
Hippocampus (all suhfields) 
CA3. OML and MML of DG 
DG and CAI 
Synapse (all kinds) 
changes 
density Size 
J, NIA 
J, @ 
J, @ 
J, NIA 
J, NIA 
d 
éj 
J, 
o 
Correlation with 
cognitive deficits 
NIA 
NIA 
NIA 
NIA 
NIA 
NIA 
NO correlation 
NO correlation 
Positive cor. with deficit 
No deficit hut positive 
cor. between 
performance and 
boutons number 
(Tigges et al. 1995) 
(Tiggrs et al. 1996) 1 EM + stereology 
EM 
(Gibson 1983) 1 EM 
(Bertoni Freddari el ai. 1990) 
(Adanis 19x7) 
- 
EM 
EM 
(Bertoni Freddari et al. 1990) 
(Scheff & Price 1993) 
(Bertoni Freddari et al. 1996~) 
(Scheff et al. 1996) 
(Scheff & Price 1998) 
EM 
EM 
EM 
EM + htereology 
EM + stereology 
(Hamos et al. 1989) (Lippa 
et al. 1992) 
(Sreet al. 1997) 
Densitometry/ 
ICC synapsiiilI 
rynaptopliysin 
Iinm.hlot/ 
synnptophysin 
tnonkey 
human 
- 
OML of DG 
IML of DG 
Frontal cortex 
Precentral motor cortex 
Postcentral somatosensory cortex 
IML of DG 
Frontal cortex 
Temporal lobe 
Ccrehellum 
OML of DG 
IML of DG 
OMLIIML of DG 
CAI,  Etitorhinal cortex and others 
cj d 
t) cj 
JI NIA 
JI + 
JI + 
Q Q 
d NIA 
Q hut neg cor sizdti 
JI + 
Q bui neg cor sizdn 
t> but NO cor sizeln 
tj 
NIA 
NIA 
NIA In non dcm. elderly 
NIA In non dem. elderly 
NIA 
NIA In non dem. elderly 
NIA In non dem. elderly 
NIA In non dem. elderly 
NIA In non dem. elderly 
NIA in  non dem. elderly 
NIA I n  non dem. elderly 
NIA In non dan .  elderly 
NIA In non dem. elderly 
Table 2 Synaptic changes associated with aging ucrms .spe<,ies. EM, electron microscopy; DG, dentate gyrus; N/A, non avuiluhle: CO size/?,., 
correlation between svnaptic size and synaptic number: non dern., non demented; neg.,negutii~e: OML, outer ML; IML, inner M L  
1.2.2 Influence of ApoE polymorphism on memory and cognitive impairment 
Studies of learning, memory and other cognitivc functions in non-demented elderly 
deinonstrate that individuals with the €4 allele have poorer performance than non &4 carriers, 
whereas those with the €2 allele perform better than all the others genotypes. Follow-up 
examination of the same groups show that subjects with the &2 allele maintain their cognitive 
performance. whereas that of subjects with other genotypes deteriorates with age (Berr et al. 
1996, Bondi et al. 1995, Feskens et al. 1994, Heikala et al. 1995, Helkala et al. 1996. 
Henderson et al. 1995, Hyman et al. 1996a, Kuller et al. 1998, Reed et d. 1994, Soininen & 
Riekkinen 1996, Yaffe et al. 1997). These data suggest that inheritance of the €4 allele is 
associated with an increased chance of developing cogiiitive impairment and dementia. 
whereas iiihcritance of the &2 allele is associated with a smaller risk lor developing cognitive 
impairment. I-lowevei-. it is impoimnt to note that inmy &4 individuals reach old age without 
cognitive deficit. Increased numbers of NFTs, increased Aß deposition and hippocampal 
atrophy described in the brain « i f 4  patients (see section i .  1.6.2) may form decades before the 
onset of dzinentin. and inay iiicreasr the risk of cognitive decline before thc clinical diagnosis 
of denientL H y m n  iilso reported a sironger effect of the €4 allele on women’s cognitive 
decline. compared to men (Hyiiian et al. 1996a). This finding is in agreement with recent 
studies in  2 d -rent lines of human ApoE transgenic mice, where 6 month old hApoE4 
females show some cogiitive deficit in the water maze task and age-matched inales are not 
impaired (Raber et al. 1998, Veinbergs et al. 1999). In contrast, most lines of ApoE knock-out 
inice display cognitive deficits, that may be related to alteration of the integrity of cholinergic 
system for some. and to iieurodegeneration in the neocoriex and the limbic system for others 
(Gordon et al. 1995, Gordon et al. 1996a, Krzywkowski et al. 1999, Masliah et al. 1997, 
Masliah et al. 1999, Oitzl et al. 1997, Raber et ai. 1998, Veinbergs et al. 1999, Veinbergs & 
Masliah 1999 but see Anderson et al. 1998). 
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1.3 Use of transgenic mice to study the role of ApoE 
In  the present thesis, the approach chosen to investigate the role(s) played by ApoE in 
the neuronal and synaptic integrity of the hippocampus is the study of ApoE deficient mice, as 
well as transgenic inice expressing the different human isoforms. The rationale behind the use 
of knock-out mice is as follows: one knocks-out a gene in vivo  and creates a mutant mouse 
that conipletely lacks the gene of interest. The comparison of the phenotypes between wild 
type (WT) and knock-out (KO) mice should then provide clues about the function of the 
protein of interest, assuming that no other proteidgene takes over the function of the inissing 
gene. Several ApoE knock-out lines have been developed in the last few years. They have 
sometimes produced contray resulis, leaving several issues unresolved. as discussed in 
previous paragraphs and reviewed in Veinbergs & Masliali ( 1999). Moreover, WT mice 
express a single ApoE isoform, which shai-es only 70% homology with the human ApoE4 
ainino acid sequence (Rajavashisth et al. 1985). Consequently, the influence of ApoE 
polymorphism cannot be examined directly. ApoE cellular localisation is another major 
difference between i-odents and priinates/humans: ApoE mRNA and expression are observed 
in neiirons u id  astrocytes in  primate and human brains whereas they are only astrocytic in 
rodent brains under normal conditions (Boyles et al. 1985, Diedrich et al. 1991, Han et al. 
1994~1, Han et al. 1994h, Igriniitis ei al. 1986, hltttzger et al. 1996, Poirier ct al. 1991, Rebeck 
et al. 1993. Xu et al. 1996, Xu et al. 1999a. Zarow ¿k Victoroff 1998). These crucial 
differences have led to ihe development of ‘human’ transgenic inice to mimic better the 
physiological expression of ApoE in the human brain. To date, 5 lines of human transgenic 
mice have been created. They differ mainly in the promoter driving the ApoE gene, the 
number of copies of the transgene, the level of expression, and the organ and cellular 
localisation. Table 3 describes the characteristics of the different lines. 
(Bowinan et al. 
1995) (Bowman 
et al. 1996) 
(Sun et al. 
1998) 
(Smith et al. 
1998) 
(Buttini et al. 
1999) 
Promoter 
Wild type'? 
ApoE KO 
(From CS7BLl6J) 
ApoE KO 
(From FVB/N and 
C57lBL6) 
ApoE KO 
(From C57BLl6J) 
-. 
Humaii ApoE 
Human 
Transferrin 
GFAP 
- 
Human GFAP 
Rat Neuron- 
spec ific-enolase 
íNSEì 
Isoforms-copy 
number 
E2-205 8 copies 
E3-437 2 copies 
E4-81 2 copies 
E2 3 copies 
E3 40 copies 
E4 2copies 
E3-2 NIA 
E4-22 NIA 
E2 NIA 
E3a-b NIA 
E4a-b-c NIA 
E3 
E4 
In Organ 
Seruin. 
brain, liver, 
kidney, 
heart. 
muscle and 
others 
Brain and 
liver 
Brain 
Brain and 
plasma 
Brain 
Tuhle 3 Current models ofApoE irnnsgenic mice 
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Expression 
Cellular Level 
distribution In  brain 
In brain 
glial 
(astrocytic) 
Glial E3 249 
(astrocytic) 
E4 21 pmoVg 
of brain 
1 homogenate 
Glial 1 Not detailed 
(astrocytic) I O. I 2 to 0.3 
1 pg/rng protein 
Glial I E2 1.12 
(astrocytic) E3 0.2 to 1.97 
E4 0.72 to 1.5' 
pglmg protein 
Neuronal 1 E3 4.4 
E4 4.6 
pg/mg protein 
The ApoE transgenic lines chosen here offer several advantages over other lines. They 
were constructed using large human DNA fragments containing the ApoE, ApoCI and 
ApoC1’ pseudogene, with human promoters and tissue expression elements in an ApoE 
knock-out mouse hackgïound (Xu et al. 1995). This way, only human ApoE is produced and 
there is no influence of endogenous mouse ApoE to confound the results of any experiment. 
Moreover, thc pattern of ApoE expression is ’humanised’ for each ApoE isoform transgenic 
line: ApoE inRNA and protein are detected in neurons as well as in glial cells (Roses et al. 
1998, Xu et al. 1995. Xu et al. 1996). Ifthe mouse ApoE gene is substituted with human ApoE 
gene by target replacement, the human gene is placed under normal mouse promoter and 
mouse expression elements, and results inadequately in a ’rodent’ pattern of ApoE expression 
as observed in other lines (Roses et al. 1998, Xu et al. 1996). Because ApoE may be involved 
in cytoplastnic mechanisms in AD and neuronal repair after head injury, both in  glial and 
neur«nal cells. this charactei-istic pattern of cxpression i n  the traiisgenic line used in this study 
represents a major advantage over other constructs. In ApoE knock-out mice, which lack 
ApoE- inediated cholesterol transport, blood concentrations of cholesterol are 6 to 7 times 
higher than those Iouiid in wild type mice. Of all the hiimnn transgenic lines produced by Dr 
Xu, wc chosc !hose with ApoC isoforiiis whcrc cholesterol concentrations were similar and 
substantially corrected. it appeared that these 3 lines were constructed with different copy 
nurrihers of the ApoE gene and consequently, differences in levels of expression can be clearly 
observed. Although this inay represent a major limitation of this transgenic model. the unique 
‘huinanised’ pattern of ApoE expression of these lines seems an essential advantage to study 
possible iinpairnient in the maintenance of neuronal and synaptic integrity, where neuronal 
intracellular mechanisms and interactions between ApoE and other proteins may be involved. 
It is important to note that despite the obvious link between the &4 allele and AD, 
human ApoE transgenic mice are not, in any case, a model of this disease. Only Aß over- 
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expresser mice lead to Aß deposition similar to that observed in the disease (reviewed in (Duff 
1998, Price et al. 1998)), whereas, for example, such events have not been repoited in any 
existing ApoE transgenic mice (Smith et al. 1998). Aß over-expresser mice still represent 
incomplete inodels of AD because they do not develop typical NFT or marked neuronal loss 
(Duff 1998, Price et al. 1998). However, crossings between various transgenic mice to 
produce double transgenic animals seem promising. For example, Aß over-expresser crossed 
with human ApoE Inice have recently been produced to examine the influence of ApoE 
polymorphism on Aß deposition in the brain (Bales et al. 1997, Holtzman et al. 1999). If 
human ApoE transgenic mice crossed with other transgenic inice are to he extensively studied 
in the future, it will he essential to characterise fully each line first. Hopefully, the results 
presented in this thesis will add to the basic knowledge necessary to pursue such complicated 
double trlinsgenic studies. 
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1.4 Objectives 
The previous sections demonstrated that ApoE is a multifunctional protein with 
important roles in neuronal plasticity and repair. ApoE polymoi-phism modulates the risk of 
developing AD and the age of onset of this disease. and it is also associated with various 
degrees of severity of pathology. Moreover, it influences the prognosis of recovery and the 
extent of neuronal damage and cognitive impairment after head injury. With the risk of 
neuronal damage increasing with age (in the context of AD or head trauma), it seems 
reasonable to think thai the influence of ApoE polyinorphisni on neuronal maintenance is be 
age-dependent. 
Multiple interactions of ApoE with key molecules have been described. However, it is 
still unclear which of the multiple fiinctions of ApoE is critical to result in these polymorph 
effects. Poor regenerative capacity o f  the &4 allele after neuronal darnage seems to be a solid 
hypothesis, although interaction with other molecules such as Aß niny also be relevant aiid are 
110 t exc I LIS i ve. 
Trnnsgenic inice have become a very popular tool nor only to study the function of 
specific proteins, but also as an attempt to inodel disease pathogenesis for the developinent of 
ihei-npeutic drugs. It is clear that species differences prevent the direct comparison between 
mice aiid tiurnanh. leading to the production of ‘humanised transgenic mice’, i.e. mice carrying 
one or several human genes coding for proteins of interest. Huinan ApoE transgenic mice are 
useful not only to study ApoE polymorphism itself, but also for the future production of 
double or triple transgenic mice expressing other protein such as Aß, towards better models of 
AD pathology. However, such studies first requke a b a i c  knowledge of single transgenic 
niice, to be able to intci-piel results in rnultiple transgenic niodels. 
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Since synaptic and neuronal integrity are important markers of neuropathology, the 
aim of this thesis was to determine the influence of ApoE polymorphism on structural synaptic 
morphometric parameters, such as synapsc number and sire, throughout the life of human 
ApoE transgenic mice. The DG was chosen as the region of interest because of its early and 
well-known vulnerability in AD. and its capacity for synaptic plasticity. 
Towards this purpose, the following goals were established: 
1 ) Compare qualitatively gross (brain and hippocampal volumes) and fine (ultrastructural) 
neuronal and synaptic morphology between the different groups of mice (WT, ApoE KO 
and human transgenic mice) 
2) Determine the normal pattern of structural synaptic changes during aging in W T  mice. 
3) Make identical nieasurerncnts in ApoE KO mice to iiifcr II possible role of mouse ApoE in  
structural synaptic plasticity during aging. 
4) Make identical measurements in human ApoE transgenic mice to examine the influence o f  
human ApoE ~~olyi i iorpl i i~m in structural synaptic plasticity during aging. 
5 )  Examine the influence of hurnan ApoE polymorphisiii on synaptic and dendritic content of 
glutamate in the DG, to gain some information about the status of synaptic transmission 
efficacy associated with ApoE genotype. 
All the measurements were performed with unbiased stereological nicthods at the 
electron microscope level to produce precise, reliable arid comparable data. 
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Chapter 2 Materials and methods 
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2.1 Transgenic mice 
Identical lines of mice were obtained from colonies bred at Duke University Medical 
Centre (DUMC), Noi-th Carolina, USA and at Glaxo-Wellcoine, Stevenage, UK. 
Wild type (WT) niice were C57BL/6J. ApoE knock-out (ApoE KO) mice were 
produced by Dr Maeda (UNC, Chapel Hill, NC) (Piedrahita et al. 1992). Embryonic stem (ES) 
cells from 1295 iiiice were isolated. Their normal mouse ApoE gene was then disrupted by 
removing a DNA fragment containing part of the ApoE gene’s exon and intron 3 ,  and 
replacing it by the neomycin-resistance gene in u iargeting plasmid. After homologous 
recombination between the endogenous ApoE locus and the targeting plasmid, the modified 
ES cells were injected into host blastocysts from C57BL/6J mice and implanted into foster 
mothers. The FI resulting animals inherited a normal and a modified ApoE allele and were 
backcrossed at least 6 times to C57BL/6J mice to remove the 129J background and increase 
tlie representation of the CS7BLí6J backgi-ouiid. This process creates a strain that cali-¡es the 
ApoE iiiutated gene oil tlie desired wild type backgïound (Gerlai 1996b). 
Heterozygous human ApoE transgenic niice were generated by Dr. Xu (DUMC. 
Durham, NC, USA) as described in detail in Xu et al (Xu et al. 1996). Briefly, DNA fragments 
containing huinan regulatory sequences and the coding sequences for the 3 isoforins of human 
ApoE were isoliitcd. They wei-e microinjected independently into single-celled embi-yos 
fertilised by ApoE KO fathers, and from mothers that were a cross of strains C57BL/6J and 
DBN2J. The resulting founder mice inherited a normal mouse ApoE allele Trom the injected 
female and an inactivated allele from the male ApoE KO donor, and also possessed the human 
ApoE transgene. They were bred to ApoE KO mice to produce animals hemizygous for 
human ApoE transgene and homozygous for KO mouse ApoE gene. Human ApoE 
hemizygous transgenic animals were bred to hoinozygoty and back-crossed further at least 6 
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times to ApoE KO mice to remove the genetic influence of DBAI2J background strains. The 
presence of human ApoE genes was confirmed by polymerase chain reaction. However, their 
localisation in the mouse genome has not yet been carried out. The mode of integration and 
copy number of transgenes were analysed by Southern blotting. Serum cholesterol 
concentrations in ApoE KO mice were 6 to 7 times higher (756 mg/dl) than that found in WT 
mice (98 mg/dl). In hApoE2, E3 and E4 mice. cholesterol concentrations were substantially 
corrected and very similar (168 to 173 mg/dl). 
In the present study, 76 mice were used, including inales as well as females. The 
detailed composition of the groups is given in Table 1. The following transgenic lines were 
used: ApoE2- line 205 (8 copies of the human ApoE traiisgene), ApoE3- line 437 ( 2  copies). 
ApoE4-line 81 (2 copies). Mice were separated into 3 age groups: young (from 6 to 10 
months), adult (from 14 to 18 months) and aged (from 19 to 24 months). 
Huinan Apolipoprotein E (hApoE) and adult ApoE KO mice were taken and perfused 
at DUMC in April 1997 and 1998, while young and aged ApoE KO and WT inice were 
obtained on ;i i-egular basis fi-om July 1996 to January 1998 froin colonie5 transferred from 
DUMC. NC, USA to Glaxo-Wellconie, Stevenage, UK. Data from mice from both sources 
were pooled for statistical analysis of the results on the assumption, that since the inice were 
bred in very similar conditions (low-fat diet. 12h darwlight cycle), the geographical 
localisation or the animal houses would not be a major factor of  variability in the results. 
The research using animals describcd in this thesis coinplied with the Home Office 
Animals (Scientific Procedures) Act 1986. The numbers of animals were the minimum 
possible to demonstrate reliable effects. 
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Viid type 
young 
udult 
old 
~ p o E  KO 
young 
adult 
Old 
ApoE3 
\'oicng 
udnlt 
old 
iApoE4 
young 
crdirlf 
old 
Number of 
animals 
17 
6 
5 
6 
16 
6 
4 
6 
13 
4 
3 
6 
23 
6 
11 
6 
Gender 
maledfemales 
1710 
6 1 0  
5 1 0  
6 1 0  
1511  
6 1 0  
410  
5 1 1  
7 1 6  
O14 
112 
6 1 0  
3 / 4  
- 
314 
- 
1716 
412 
714 
6 1 0  
ige range 
(months) 
8 
16 
21 
8 
17 
22 to 24 
10 
14 to 16.5 
19 to 22 
- 
I4 to i8 
- 
6 
15 to 17 
I9 to 20 
61 
2.2 Perfusion. 
Mice were anaesthetised with an intraperitoneal injection of sodium pentobarbitone 
(0. Iniv30g body weight of SAGATAL 60 mg/inl) and then perfused transcardially with 15 in1 
of 0.9% saline solution followed by 150 inl of 2% glutaraldehyde and 2% paraformaldehyde 
in 0.1 M phosphate buffer at room temperature (See Appendix for solutions recipes). A 
peristaltic pump delivered the solutions at a flow rate of 4.lml/min. The whole brains were 
removed froin the skull and placed in fresh fixative overnight at 4°C. 
Tissue sampling differed for subsets of animals. depending on which experiments they 
were included in. This is described in detail in section 2.3 for hippocampal and brain volume 
estimation and in section 2.4 for electron and light nicroscopy. 
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2.3 Volume estimation. 
The voluine of the brain and the v«lume of both right and left hippocampi were estimated for a 
subgroup of 15-19 month old mice (detailed in Table 5 )  using the Cavalieri method (Cavalieri 
1635, Howard 1998). Each brain was sectioned horizontally using an Oxford vibrating 
microtome into 150 Krn sections. One in three sections was stained with u solution of 0.01%’ 
toluidene blue in O. iM phosphate buffei- for 15 niin and then washed with buffer, resulting in 
IO- 12 sections from the whole brain (see Appendix for solutions recipes). The sections were 
lefi in 0. IM phosphate buffer at 4°C foi- 2 days so that the cell layers were very distinct. Each 
section was mounted on a glass slide, scanned with a Umax flat-bed scanner and printed on 
paper to a iniignification of 10. The delineation of the hippocampus was made according to 
well-known ai-chitectonic and topographic data (Sidman et al. 1971) and included Ammon’s 
horns. the DG and the subiculuin. The olfactory bulbs and the cerebellum were excluded from 
the measurement of brain volume. The areas of the hippocampi and the brain were estimated 
by counting the numbers of points that hit a quadratic lattice superimposed on the image. The 
size of  ihe grid in relation to the size of the printed image was such [hai appIoximately 100 
and 200 points foi- tlie hippocainpus and the brain respectively. were counted in the 10 to 12 
sections. The calculated arcas, the section thickness and the distance between sections were 
then cntcrcd i n  the Cavalieri formula to calculate the voluine: V = T x a/p x Z,”’ PI where T is 
the distance interval between 2 scctions, d p  is the area associated with each point of the grid 
and Z,”’ PI is the nuinber of points landing within the transect of the region of interest 
(hippocampus oi- whole brain) on the i“’ section (see Figure 2.1) 
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2.4 Electron microscope processing. 
3 transverse slabs of limn thickness across the entire dorsal hippocampus from both 
right and left hemispheres were dissected for each animal. The tissue was then prepared for 
electron microscopy by postfixing in 1% osmium tetroxide for 1 h. dehydrating through a 
graded series of acetone before embedding in Epon resin (see Appendix for solution recipes 
and procedures). Blocks were polymerised at 60°C for 24-48 h. Ultrathin sections of silver 
interference colour were cut on an ultramicrotome with a diamond knife and mounted on 
2x1 inm slot grids with Pioloforidcarhon (see Appendix for solution recipe) support film. Pairs 
of serial sections were mounted on the same slot grid and stained with uranyl acetate and lead 
citrate (see Appcndix for procedure). 
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2.5.2 Mean synapse density N, 
Synapse density per cubic micron was estimated using a disector in the MML of the 
DG (Figure 2.4 and Figure 2.5). Twelve pairs of digital images of the sections were acquired 
along the axis of the cell layer, from a JEM 1010 electron microscope at a magnification of x 
12000 using a Kodak Megaplus digital camera. On the digital images, synapses were 
identified by the presence of both pre- and post-synaptic dcnsities, with an associated vesicle 
cloud in the presynaptic bouton. They were then classified as shaft or spine synapses 
depending on the nature of their postsynaptic site. Thc sum o f  shaft and spine synapse 
densities provided the total synaptic density for each mouse. The section thickness was 
determined by the electron scattering method (De Groot 1988). The results presented were 
obtained by counting a total of 14482 specific synapses (average of 190 synapses per mouse) 
in the MML of the DG. 
2.5.3 Mean neuron density N, ",,, 
Granule cell density per cubic micron in the DG was estimated using the same disector 
method. Pairs of adjacent transverse sections of 2 pii thickness wei-e prepared from the same 
blocks uscd foi- synapse density estiination and stained with 1% toluidene blue in 5% borax 
(see Appendix for solution rccipe). For each animal. 3 pairs of digital images along the upper 
limb of the DG were acquired from a light microscope at a magnification of x 80 using a 
microscope mounted caiiit^Iii interfaced to a Joyce-Loebl Magiscan MD system. 5330 specific 
neurons in total (average of 70 neurons per mouse) were counted in the granule cell layer of 
the DG. 
2.5.4 Mean number of synapses per neuron Syrúnrn 
Combining estimates of N, ryn and N,. 
number of synapses per neuron, Syn/nrn= N,. syii/ N, nl,,. 
allows the uwbiased estiination of the mean 
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2.5.5 Total apposition zone (AZ) area S, 
The deternrination of the total apposition zone (AZ) area per cuhic inicron Sv was 
estimated using another unbiased stereological method (Rusakov et al. 1998, Underwood 
1970). All the postsynaptic densities (PSD) profiles were observed on the same digital images 
used to estimate the synapse density. In each sampling fi-ame, all identified PSD profiles were 
outlined as curvilinear binary segments using cursor editing tools. The background image was 
cut off using grey level thresholding. The accumulated length of all curvilinear segments was 
automatically measured in each image using an algorithm developed in the laboratory and 
stored on a file. This accumulated length was then divided by the frame area, to obtain the 
PSD length per unit section area, LA*. Finally, the value of total AZ area, S ,  was derived 
directly fromLA (Underwood 1970): S, = 4.(LJ i n where L,\ is the mean value of LA* across 
the smiple of  digital images. In  total, 8 to 10 frames per mouse were analysed, to provide 90 
to 1 10 profiles per animal. 
2.5.6 Mean apposition area per synapse Mean AUsyn 
Combining estiinates of S,. and N,2 allows the unbiased estimation of the mean 
apposition zone area of individual PSDs, in other word the area of individual synapses: Mean 
AZ/syn = S, I N, 
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2.6 Brain tissue shrinkage 
In the saine group of nice used for brain voluine estimation (Table 5 )  ineasureinent of 
the volumetric coefficient of shrinkage K,: was performed on 1 5 0 p  sections. One piece of' 
temporal cortex per animal was imaged twice using a Umax flat-bed scanner: first in 
(chemically) 'fixed' state and mounted on a glass slide, then when embedded in Epon, 
following the procedure described in paragi-aph 2.4. The visible area of the slice A was 
measured using an image analysis routine in NIH Image, providing A and AE~, values, before 
and after EM processing rcspectiveiy. AEM /A represents the squared linear shrinkage factor 
K,,,,* (Rusakov et al. 1998). The volumetric shrinkage factor K,",' is then calculated. The 
percentage of shi-inkage is expressed 21s ( 1  - K3) x I O0 for each transgenic group. 
Ideally, the shrinkage should be calculated for the processing of fresh and not îixed 
tissue, up to the embedding stage (Uylings et al. 1986) and from hippocampal tissue. 
However, because of the scarcity of the transgenic mice used, especially at the older ages, only 
tissue from perfused mice could be used. 
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2.7 Choice of ratio estimates for final statistical analysis 
To avoid bias of results due to differential shrinkage related to age (Haug 1985) or 
ApoE genotype, it was considered relevant to take into account only measurements that were 
independent of volume (see explanation in Results, section 3.3). Whereas densities are 
estimated per unit volume, ratios of densities eliminate the volume factor for objects counted 
in the saine tissue. To be able to interpret the data in a bias free fashion. statistical analysis was 
performed with synapse quantitation expressed as Syn/nrn, and synapse size expressed as 
Mean AZlsyn (Ceinisman et al. 1992, Mayhew 1996). It is impoi-tant to note that ideally, the 
final results of any morphoinetric study should relate to each animal (Howard 1998). This 
implies that the final measurements should be the total nuiiiber of synapses and total AZ area 
per DG per inouse. In ílieory. these values could he obtained by multiplying densities by the 
volume of reference where these halje been measiired, i.e. voluine of the DC. However, in 
practice in this study, the limited availability of mice and the geographical location of the 
suppliers prevented the application of this principle. Nevertheless, ratios are have been used in 
a number of studies (Geinisman et al. 1991, Geinisman et al. 1997) and are widely accepted as 
pertinent ineasureinents. 
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2.8 Immunocytochemistry quantitation 
2.8.1 Electron microscopy immunocytochemistry 
Post-embedding imrnunogold electron microscopy was performed on ultrathin sections 
froin Epon embedded tissue. All the transgenic groups were treated equally in this experiment. 
Up to the sectioning stage, the preparation of the tissue was similar to that described in 
paragraph 2.4. Sections of dark gold interference colour (thickness of approximately 100 nm) 
were cut and collected on 50-niesh carbon/pioloform-coated copper grids. The sections were 
air dried for 1 to 2 days. They were placed in a Leica grid support plate and treated with a 
saturated aqueous solution of sodium metaperiodate for 20 minutes in a glass Petri dish at 
room temperature. This reaction partially etches the resin surface and removes some of the 
osmium froin the tissue at the section surface. After 3 washes in distilled water, the plates 
supporting the grids were incubated in 0.01M sodium citrate buffer (pH 6 )  (see Appendix for 
solution recipe) for 10 minutes in  a preheated oven at 80°C. A plastic lid covered the Petri 
dishes to avoid excessive evaporation. After heating. the grids were allowed to cool at room 
temperature for 15 minutes. The combination of treatment with sodium metaperiodate 
í'ullowed by licating on ciirate buffer unmasks the antigens and increases immunolabelling 
(Stirling & Gi-all 1995). Following several attempts to obiain reasonable labelling, this method 
was choscn over conventional etching with sodium metaperiodate and sodium borohydride. 
After 3 washes in distillrd water, thc grids wci-e taken off the trays and placed on top of 20p1 
drops in a Parafilm-lined box for all the following steps at rooin temperature. Non specific 
antigen binding was blocked with a microfiltercd solution of 5% bovine albumin serum 
(Sigma A7030) and 2% normal goat serum (Sigma) in PBSA (BSA/NGS/PBSA) for 30 
minutes (see Appendix for solutions recipes). The grids were then transferred to the rabbit 
anti-glutamate primary antibody solution (Sigma, UK) at 1:lOO in 5% bovine serum albumin 
in PBSA (BSNPBSA) for 1 hour, and washed 3 times for 5 minutes in BSNPBSA. They 
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were then incubated for 1 hour in goat anti-rabbit IgG conjugated to 15 nm gold (British 
Biocell international, UK) diluted 1: lOO in BSAíPBSA. After 2 washings of 5 minutes in 
BSNPBSA, the grids were finally incubated in O. 1% aqueous glutaraldehyde solution for 5 
minutes to prevent the removal of gold conjugate during staining. The sections were then air- 
dried and stained with uranyl acetate and lead citrate in a LKB ultrastainer. The specificity of 
the reaction was assessed in several ways. Firstly, the primary antibody dilution of 1:100 and 
the addition of 2% NGS in the first step were chosen after pilot experiments, so that there was 
no labelling in the lumen of vessels after incubation with both primary and secondary 
antibodies. Secondly, control grids were incubated with either normal rabbit serum at I: 100, or 
with no primary antibody, and were processed in parallel throughout the whole 
immunocytochemical reaction. 
2.8.2 Quantification of the ICC reaction 
I O  micrographs per animal were acquired along the axis of the cell layer, in the MML, 
from a JEM 1010 electron microscope at a magnification of x 12000. Negatives were scanned 
with an Agfa flat-bed scanner to produce digital images for the analysis. The density of gold 
particles was assessed i n  presynaptic boutoiis and in dendritic processes. Presynaptic boutons 
were identified by the presence of both pre- and post- synaptic density, with an associated 
cloud of synaptic vesicles in the presynaptic bouton. No attempt was made to distinguish 
synapses of syiiiiiietrical and asymmetrical types, o r  to count only gold particles that were 
contained in synaptic vesicles. Dendrites were identified by the presence of microtubules. 
The outline of the compartment of interest (bouton or dendrite) was drawn and its area 
measured with a measuring tool in NIH Image software. The number of gold particles was 
counted in each coinpartment. All the compartments that contained 1 or more gold particles 
were measured. Mitochondrial profiles were excluded from both area and gold particle 
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ineasurements. The sum of all the counted gold particles was divided by the sum of all the 
measured areas to provide the number of gold particles per square inicroineter of presynaptic 
bouton or dendrite for each mouse. Both measurements were averaged for each ApoE 
transgenic group. 
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2.9 Statistical analysis. 
Data were evaluated with the statistical package Statistica (version 5). Estimated 
synaptic (shafi, spine and total) densities, neuron density, total AZ area per unit volume, mean 
AZ area per synapse, hippocampal and brain volumes. were calculated for each mouse. Values 
from individual mice were averaged to obtain the group mean & standard error of the mean 
(SEM), for various age- and ApoE genotype- groups (group profiles shown in Table 4). 
An analysis o f  covariance (ANCOVA) helped evaluate ihe effect of ApoE genotype or 
the effect of age o n  the synaptic morphological p;irnmeters. Since there were small age 
differences within individual groups. age was always taken as a covariate to match groups that 
were compared. Finally, differences between groups of age 01- ApoE genotype were detected 
by a least square difference (LSD) test as post-hoc analysis. 
The level o f  significance \vas taken as P<0.05 
Chapter 3 RESULTS 
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3.1 Qualitative analysis of hippocampal anatomy and 
synaptic ultrastructure. 
3.1.1 Hippocampal anatomy: light level analysis. 
The gross anatomy of the hippocampus was examined from semithin sections for each 
group of mice (Figure 3.1). All the hippocampal fields had a normal appearance in all the 
groups. There was no sign of aberrant development of cell layers or fibre projections at that 
level of observation. 
3.1.2 Synaptic ultrastructure: electron microscope analysis. 
Examination of electron micrographs (Figure 3.2 and Figure 3.3) taken in the MML of 
the DG showed that there were no obvious synaptic alterations, similai- to those described in 
the brain of AD patients (Masliah et al. 1989. Masliah et al. l991b), in any line of transgenic 
mice at any age. The synaptic terminals were generally l ~ i l l  of numerous round and regular 
synaptic vesicles accompanied occasionally by normal mitochondria. There was neither 
enlargement of the terminals. nor the presence of rnultilainellar or elecii-on dense bodies that 
are cliaractcristic oí AD neuropil. Microtubules in  tlic dendriieh were rcgularly arranged with 
n o  sign of disassembly or disruption. 
The integrity of granule cells in the DG was similar in all ApoE transgenic lines 
(Figure 3.3) .  There was no evideiice of neurodegeneration as indicated by either the absence of 
chromatin condensation in the nucleus. or absence of distention or vacuolization of the 
cytoplasm. In AD patients, neurofibrillary tangles are evident occasionally in the granule cells 
of the DG (see example of N F I  in frontal coitcx of AD patient in Figure 3.4). However, such 
neurofibrillary pathology was not observed in any of the transgenic groups. 
Several markers of normal aging were present in older aniinals. Clusters of granules 
were observed in the ML of the DG as well as in  CAI (Figure 3 . 3 ,  often localised around 
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blood vessels. At high magnification in the EM, they contained fibrillar material, almost 
crystalline-like, and in many cases without membrane around thein. The incidence of these 
granules seemed to increase with age. Although they were not quantified, there was no 
obvious difference in their number between the different groups of mice. Such granules have 
been reported previously i11 C57BL/6 mice. They are found closely associated with astrocytic 
processes and are iinmunopositive for HSPG and Iaininin (Jucker et ai. 1992, Jucker et al. 
1994, Kuo et al. 1996). Although the functional significance of such deposits is unclear, they 
do not represent senile plaques with A ß  deposition, and they are not related to spatial memory 
performance as measured in the Morris water maze (Jucker et al. 1994). 
Lipofuscin iniracellulai- deposits also appeared io increase during aging in all the 
groups of mice. They were localised either in astrocytic cell bodies in the neuropil of the 
MML or in the soma of granule cells (Figure 3.5). Lipofuscin and ceroids are 2 types of 
lipopignieiits arising froin the accumulation of indigestible residues in lysosomes. They reflect 
the lysosomal degradative efficiency. Whereah hydrolase activity increases early i n  AD within 
late endosomes and inuturc Iysosornes, lipofuscin is either unchanged (Mann et al. 1984) or 
modestly increased (Dowson 1982). It is still unclear whether this accumulation o1 
lipopigments has adverse effects. No attempt was inade to quantify this type of deposit in 
relation to ApoE genotype in the diffei-ent groups of mice. 
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Figure 3. I Cornpcirison cf the gross uriutoiny ($ tiir hijJpoccunpus between W, ApoE KO, 
hApoE2, hApoE3 and hApoE4 I 9  month old mice. Semithin sectinm were sterilied with 
toluitiene blue. BG, dentate gyrus; f i , jimhrici; S,  srrhicirlurn; L'C, entorhind cortex; ml, 
moleculur luyer; gl ,  grunule cell layer; 11,  hiliis; I d ,  pyruinidul cell layer; so, strutum oriens; 
s l ,  .strutriiii Iiicidiriii; sr, strutuui i-cidiciiuriz. S u l e  beir i s  lrnm. 
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Figure 3.2 Comjmisori oJ the .syurq~/ic ultrustruciure i n  the neuropil. Magii~ficution f o r  all 
niicr-i)grtiph.s i s  x 45000. Tissue IVUS tukeri .from the M M L  i$ W, ApoE KO, hApoE2, hApoE3, 
hApc~E4 19 nzonth old niice unti froin the teniporul corte.x of un 80 year old A D  patient. 
Nirrtierous .synaptic contacts o('c11r on deiitlritic spines ( s i .  In all rnou.se groups, presynaptic 
boutom (hi corituin nhundurii round synuptic i~esides (urroiv heudsj. The > n i C ~ w t l h h U / e S  
(ui.row.s) cire regultirly uligned in tl(~ndt-itic she$ ((1). Iri  coiitrust, iri  the A D  brain, some 
pre.syiinptic teniziiiuls uve s e i ~ r e l y  rlistmdcd hut .still con/uiiz iiurnerous iwicles. Sonle 
ivsic1e.s ure cleur u r d  eirlurged (operi arroii,.~). Other pre.s~iitipti<: /er-nririu1.s hui1e lost u11 their 
syriuptit i-esitles (usterisk). 
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Figure 3.4 Comparison of’ iieimiual iulegrify hefit.eeii ,yr-tirzulr cells ,from WT, ApoE KO, 
hApoE2, hApoE3, hApoE4 I 9  morirh old micc c i r i t l p ~ ~ i ~ i ~ i i t l t r l  cell.fi-oi11 remportil c’oriex o j A D  
ptitieiir. The cell bodies of the grtiriule ce1l.s aro densr l ,~  pucked in the grtiiiule cell luyer, with 
IZO .sigiz of’ cytoplasmic rlysfimction. The i 7 U C k L i s  is romid um1 exhibits normul chromutin 
tli.strihutioii iri all mouse groups. S m d  lip(?fu!fu“ciii (L)  cleposits ure present in the cytoplasm. In 
the pyrumidul iieruon ,from the AD cuse, li/10j5i.sciri gruiiu1e.s are more uhundunt and paired 
helicul,fiiamenr.s (prf) la): iti the cell body iii (iflume shtipe, ,forming a typical neurofïbrillury 
iuiigle. The uih.seiice of rieurorral membrtme cirourzd the cell body and the lack o j  muterial in 
rhr riucleiis ( i l )  .srcggf”st thtit this ircuroiz h c i s  reriched U I I  crdiwiced .sttifie of’nriirodejierzercrtioii. 
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Figiirr 3.5 Ti.iw types of deposits typically ohseived i i i  the neuropil of mice. A cluster of 3 
gruniiles ( A )  .siirroiirid.s u cupillary. At higher inu~~iif lcc~tion ( B ) ,  the graniiles (urrows) 
rrpresent uggregutioii oj,fïbrillor mtrteriul wid .someiimes contuin mitochondria (usterisk). 
Syiiuptic coiitacts are iiot preseiit on the membrtme surroimdii?,y this inclusion rmd riot all 
ir ic l i ts ioi is  ure boirnd b.v a menibrnne. C a i d  D respectively show lipofuscin deposits (arrows) 
¿ri un ustruqtic process in mouse rzruïopil, and po.ssihly in il rlegeneriited cell hod]) iri the 
neuropil ($AD putieizt. 
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3.2 Influence of ApoE genotype on brain and hippocampal 
volumes. 
Cerebral atrophy is a macroscopic change characteristic of AD but also of human 
aging. Post mortern histopathological studies and magnetic resonance imaging (MRI) allowing 
voluine measurement i i i  isivo, show that the hippocampal formation is one of the earliest and 
most affected structures. In normal aging, hippocampal shrinkage is associated with mild 
memory impairment (Jobst et al. 1994, Goloinb et al. 1993): and similarly in AD, atrophy of 
the hippocampus occurs early in patients with the inildest dementia (De Toledo Morre11 et al. 
1997, Jack et al. 1992). I t  correlates with scvci-c iieui-ofibrillary changes and neuronal loss but 
not with Aß deposition (Bobinski et al. 1996, Bobinski et al. 2000). The rate o f  atrophy has 
been estimated to be I O  tiines gi-eater per year in AD coinpared to noi-inal aging (Jobst et al. 
1994) aiid some have suggested using hippocainpal atrophy detected by MRI to increase 
diagiiostic accuracy and to follow disease progression (Bobinski et al. 2000). 
In the CAI rcgioii. up to 92% of pyraiiiidal cells ai-e lost in the riiosi severe AD cases. 
As a consequence, hoth cellular and dendritic layers arc affected by atrophy (Bobinski et al. 
1996. West et ill. 1994b). The DG is affected by neurofibrillary pathology only in late-stage 
AD (Braak & Braak 1991) and its granular cell layer loses 25% of its volunie (Bobinski et al. 
1996). Furtheriiiore. the voluine of the iiiolecular layer is decreased by 4996, probably due to 
the severe aiid early loss of its projection cells in the EC (Braak & Braak 1991, Bobinski et al. 
1996. Hyman et al. 1986). 
The influence of ApoE genotype on voluine changes in normal aging and in AD is not 
clear. Some authors have reported a decreased volume of the hippocampus and the temporal 
lobe in &4 AD patienis (Geroldi et al. 1999, Lehtovirta et al. 1995) and in ~4 normal subjects 
(Tohgi et al. 1997) coinpared to non-&4 carriers. Others liave observed no ApoE isoforni- 
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related difference of hippocampal volume (Jack et al. 1998), and of total white matter of the 
brain (Azher et al. 1999). Yasuda (Yasuda et al. 1998) found a positive correlation between 
total brain volume and number of &4 alleles. Although methodological variations may account 
for these discrepancies, these data also suggest that various regions of the brain may be 
affected differentially by the ApoE isoforms (Geroldi et al. 1999). One recent study claimed 
that inheritance of the &4 allele increases the rate of brain atrophy in demented patients, as 
assessed by measurement of ventricular volumes, but failed to detect significant reduction of 
volume in the brain and temporal lobe in ~4 patients (Wahlund et al. 1999). 
Volumetric ineasurements in the brain of rodents are very rare. As yet only 2 studies 
have examined the effect of aging on voluinc changes in  rhe rat hippocampus and described 
very limited changes to the DG (Rapp et al. 1999, Coleman et al. 1987). Although volumetric 
studies wirh transgenic mice used as a model for AD are currently ongoing in our laboratory, 
they have not yet been published (Claire Kendal, unpublished observations). 
In  this section. brain and hippocampal vol~irnes wcrc measured by Cavalieri’s method 
in  15-19 rnoiiih old IiApoE2. hApciE3 and hApoE4 mice. io examine the possible influence of 
ApoE polyniorpliisni on brain structure. 
3.2.1 Results 
This study was carried out on brains of inice that were collected fi-om DUMC in 1998. 
Although every effort was rnade to choose inice of similar age, there was a small but 
significant difference in age between the groups (see Table 5) .  
Line 
17I1  
15.6I0.2” 
n Age (months) 
Tdde  5 Projiles (f niice used j b r  bruin und Iiippocmiipal iwlume estimation. Mean age 
kS.E.M. is .si,ynrfïcantly greater in tlie 11ApoE2 group compared to hApoE4 (p=0.0009 
indictrted by *). 
Since atrophy correlates with age in humans, the 3 transgenic groups were age- 
matched for the following statistical analysis by using an ANCOVA with age as a covariate 
3.2.1.1 Brain volume 
There were no signiîicant differences in either brain weight or volume amongst mice 
of different ApoE genotypes (Figure 3.6). 
3.2.1.2 Hippocampal volume. 
Hippocampal volume in hApoE4 mice was 6% and X %  smaller in comparison to 
hApoE2 and hApoE3 mice respectively (Figure 3.6). However, this trend failed to reach a 
level of stritistical significance. Conibininz individual genotypes into €4 positive and €4 
negative groups (i.e. hApoE2+ tiApoE3) did not change the p value to a level of significance. 
Neuronal and synaptic degeneration inay represent the microscopic correlate of the 
gross hippocaiiipal atrophy seen during aging and AD in huinans (Bobinski et al. 1996, 
Mizutani & Kasahara 1997, Siinic et al. 1997). Therefore, a possible relationship between 
hippocampal voluine and total synapse deiisity, neuron density or synapse per neuron ratio in 
the DG, was examined in the 3 groups of ApoE transgenic inice. There was no significant 
correlation bctwcen hippocampal volume and these parameters within each transgenic group, 
or within ~4 positive and E4 negative groups, or when all gi-oups were pooled. 
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3.2.2 Discussion 
These results showed that there was no difference in brain volume between hApoE2, 
hApoE3 and hApoE4 transgenic mice at 15-19 months of age. There appeared to be a trend 
towards decreased hippocampal volumes in hApoE4 mice, but this difference did not reach a 
level of statistical significance with other genotypes. 
This lack of pronounced effect of ApoE polymorphism on brain and hippocampal 
volumes might be interpreted in several ways. From a statistical point of view, the size of the 
groups used here was small (n=2-5) and inter-individual variability may cause overlap of data 
and prevent significance of differences between groups. More animals in each group are 
clearly desirable io refine the precision of volume estimates. 
Neuronal degeneration, synaptic loss, dendritic remodelling and changes in glial cell 
population are all factors that can modulate the volume of brain tissue. As shown later in 
section 3.4, hynapse density, granule cell density and synapse per neuron ratio were estimated 
in the DG of these transgenic inicc. Thcrc was no corielation betweeii any of these parameters 
aid the volume of the hippocampus. This result was expected because the DG only represents 
a portion of the whole hippocampus and variations of morphological parameters in other 
hippocampd stxiors inay countcraci those observed i n  the DC. Moreover, marked diffcrences 
betweeii hApoEZ. E3 and E4 regarding synaptic numbers appear in life later than the age point 
chosen foi. this volumetric study (described in section 3 . S ) ,  suggesting the possibility that the 
trend observed at 15-19 months of age may be accentuated at an older age. 
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3.3 ApoE genotype and tissue shrinkage 
A prerequisite to the study of morphological changes associated with aging at the EM 
Icvel is to ascertain that measurements made in young and old animals are comparable. 
Changes in brain tissue volume during EM processing have been well described. Shrinkage of 
the tissue is age- dependent, i.e. brain tissue shrinks more when taken from young than old 
individuals (Haug 1985, Haug et al. 1984). Sources of variability in volume include mostly 
dehydration before resin embedding. but also the extraction of lipid constituents of membranes 
and any variation in content and organisation of cytoskeletal elements and organelles among 
cells and tissue (King 1991). Notably, ApoE is known to play a role in lipid transport (Mahley 
1988) and in microtubule aïseinbiy (Nathan et al. 1995, Strittmatter et al. 1994). Although no 
differcnce in lipid composition of membranes related to ApoE genotype has yet k e n  reported, 
thcre are indications that in humans cholesterol and phospholipid concentrations in the CSF 
vary with ApoE genotype (Yamauchi et al. 1999). Moreover, cholesterol distribution in 
synaptic membranes and phospholipid content are niodiïied in ApoE knockout inice compared 
to wild type animals (Ighavboa et al. 1997, Lomnitski et al. 1999). Therefore, the possibility 
that tissue from the 3 ApoE isoforin transgenic mice could shrink differentially was 
investigated. 
3.3.1 Results 
There was a statistically significant diffei-ence in tissue shrinkage related to the 
genotype of ApoE transgenic mice. Tissue taken from the temporal cortex of hApoE4 mice 
shrank significantly less compared to that of hApoE2 and hApoE3, which were both very 
similar (Table 6). 
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Line I %Shrinkage 1 n 
hApoE2 16.2k1.5* I 5 
I I 
hApoE3 I 15.9k1.2** I 2 
Tuhle 6 Shrinkage .f' tevipord cortex tissue dirr-iiig EM processing in ApoE transgenic mice. 
%shrinkrige is the meunf i .  E.M. Srtrtisticiilly sigriifïcorzt diflei-erices from IiApoE4 group are 
iïidicntetl by * (p=0.003) and ** (y=0.018). 
3.3.2 Discussion 
These results obtained from 15-19 nionth old mice showed that ApoE genotype is 
associated with different degrees of tissue shinkage during EM processing. The reasons for 
this differential shrinkage are not known and such an effect has never been reported before. 
The lipid composition ofbrain tissue is likely to influence the degree of shrinkage (King 1991) 
and may be modulated by ApoE genotype (Igbavboa et al. 1997, Yamauchi et al. 1999). 
providing ii possible link be.tween these last 2 parameters. Determining the effect of ApoE 
polymorphism on the composition and biophysical properties of cellular membranes may help 
understand the role of the 3 ApoE isoforms in lipid redistribution and neuronal regeneration 
(Poirier et al. I W I .  Poirier et al. 1993;~). Whether the hhrinkage values obtained here also vary 
with age is nnkn i iwn .  Hii~ig (HLILI~ 1985) establislied clearly that brain tissue shrinkage is age- 
dependent in normal humans. This suggests the possibility of additional age-related changes of 
tissue shrinkage in ApoE transgenic mice. 
Taken together, these findings justify the later use of volume density ratios which are 
independent of volume changes, for bias-free comparison of synapse number and size between 
the different ApoE transgenic groups, at different ages. 
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3.4 Synaptic and neuronal morphometry in the dentate gyrus 
of ApoE transgenic mice. 
The aim of the following 2 sections (3.5 and 3.6) is to deterinine the influence of ApoE 
gcnoiype on syiiaptic morphological changes associated with aging in the DG. Alterations in 
synapse number and size with aging have been reported previously in other species such as 
huinans and rats (see Table 2 in introduction 1. i ) .  However, they have not yet been described 
in mice at the EM level, although this species is now used very commonly for aging research 
and for the development of transgenic models of neurodegenerative diseases. 
Several morphometric parameters were estimated, using strict stereological methods, 
first in the brain of \vild typc mice to provide a basic knowledge, and then in genetically 
inanipulated mice relevant to ApoE polymorphism. 
Synaptic (shaft, spine and total) densities, granule cell density and total AZ area were 
first estimated i n  tlie DG of WT, ApoE KO, hApoE3, E3 and E4 mice ai 3 age points (young, 
adult, aged). As established previously i n  seciions 2.7 and 3.3, density measurements cannot 
he used as such ií'they are to be coinpared bct\veeii young and old animals. Ratios of densities 
were therefore calculated to avoid the bias introduced by differential shrinkage. 
All these riicasurements and calculated values are presented in Table 4. They are 
further descrihed in  section 3.5 which examines the influence of ApoE polymorphism on 
synaptic parameters during aging for mice of different genotypes (Figure 3.7-Fi,~ure 3.10). 
whereas section 3.6 compares these same synaptic characteristics for mice of different 
genotypes at each of the 3 age points (Figure 3. Il-Figure 3.15) 
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3.5 Synaptic plasticity associated with aging varies with ApoE 
genotype. 
3.5.1 Results 
3.5.1.1 Wild Type mice 
CS7BL/6 inice are the most commonly used strain in neuroscience and aging research 
today. They perform well in tests of memory and cognition such as the Morris water maze 
(Gerlai 1996b, Owen et al. 1997, Roullet & Lassalle 1995). They also are good breeders and do 
not exhibit any particular neurological and anatomical defects, as opposed to other inbred 
strains of inice (reviewed in Gerlai 1996b. Lathe 1996). Therefore, they provide a good genetic 
background to study the effect of a missing gene in KO animals. or the effect of an added gene 
in transgenic animals. Howevcr, very few studies have characterised age-related morphological 
changes in the brain of this strain (Calhoun et al. 1998a, Ingrain & Jucker 1999, Jucker et al. 
1992, Jucker et al. 1994, Kuo et al. 1996) despite its use in transgenic models of 
neurodegenerative diseases. Here. the synaptic rnorphological changes associated with aging in 
the DG of C57BL.h iiiice are dcscribed, using unbiased stereological tools at the EM level. 
These data cire provided as controls for ApoE KO mice (section 3.6). Whereas the spine 
Sydnrn ratio did not vary significantly with age (Figure 3.7) ,  shaft synapses notably decreased 
in nurriber between young and adult age (-64%) until older age (-50%). Since shaft synapses 
only represent a siiiall proportion of all the synapses in the MML of DG (4 to 9%), their 
variation did not affect the total Synínrn ratio, which showed a similar pattern of changes as the 
spine Syn/ni-n ratio. Synínrn ratio for the adult group was 20% and 24% smaller compared to 
young and aged groups respectively but these variations were not significant. The mean AZJsyn 
remained stable until the old age. In conclusion, WT mice showed no significant age-related 
changes in either overall synapse per neuron ratio or mean AZ/syn ratio. 
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3.5.1.2 ApoE KO mice 
Sydnrn ratio for both shaft and spine symapses showed very similar age-related changes 
to those observed in ìVT mice. The number of shaft synapses per neuron dropped significantly 
by 52% and 55% between young and adult/ old age respecLively. In contrast, the Sydnrn ratio 
for spine and total synapses remained very stable throughout the age span. Surprisingly, their 
mean AZ/syn increased significantly by 25% between the young and adult time points to 
eventually drop back significantly to a similar level to that of  the young group in old age. 
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17 Young n=6 
Adult n = 4  
Aged n=6 
Figure 3.8 Synaptic chcirzges in the MML of BC cis.sociutrci wifh riging ,for ApoE KO mice. 
Meun A U s y  is expressed cis p m  per synapse. Dato cire i i iemLSEM. SlntisticcilZy signijicant 
dijferences cire iizdicatetl by cisrerisks (p<O.OS). 
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3.5.1.3 hApoE2 mice 
None of the categories of synapses was affected by aging, as indicated by their 
unchanging Synhrn ratio across ages. The mean AZ area per synapse, however, decreased 
steadily, falling by 20% in aged compared to young mice. Notably, mean M s y n  correlated 
negatively with age (r=0.68, p=O.O1) in the whole sample of hApoE2 inice (n=13). 
1 O 0  

3.5.1.4 hApoE4 mice 
hApoE4 mice showed the most pronounced morphological changes associated with 
aging; all populatioiis of synapses were affected, both in number and size. The shaft Synínrn 
ratio increased non-significantly between the young and adult time points but then dramatically 
decreased by 78% in aged mice. The spine Sydnrn ratio declined steadily from the youngest 
age and was 32% snialler in aged mice compared to young ones. Similarly, the total Synínrii 
ratio decreased significantly with age, such that the aged group had 34% less synapses per 
neuron in comparison with the younger animals. This phenomenon was accompanied by a 
parallel increase in the mean AZ area per synapse of 22% between young and aged mice. 
Indeed, inean AZsyn correlated positively with age (r=0.47, p= 0.02) in the whole sample 
population of hApoE4 mice (i1=23). Notably. an opposite negative correlation was found in 
hApoE2 mice. 
A decrease in the Syidnrii ratio observed in hApoE4 mice can be interpreted in  2 inain 
ways: a decrease in synapse density or a n  increase in neuron density (01- a combination of both) 
during aging. Measiireinents of both these parameters ai-e presented in Table 4, and show an 
increasc of both hynaptic and neuronal densities in hApoE4 niice during agiiig. Again, these 
ruw values should be considered with caution because tlicy are not corrected for sbinkage at 
the 3 age points. Although the increase in neuron density suggests that it is the cause for the 
decrease of the Synínrn ratio, additional measurements ruled out this possibility. The thickness 
of the granule cell layer was measured at the 3 age points (Tahle 8). In aged animals, the 
granule cell layer was significantly thinner than at earlier age points. 
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hApoE4 mice Young Adult 
Thickness of 68.6+5.2 74.1t3.7‘ 
granule cells layer 
(pm) 
Granule cell density 0.001010.0001 0.001 I-tO.0001 
per wm3 
n 6 I l  
This implies that tissue from aged hApoE4 rnice shi-inks more (either ir? v i i ~  or during 
processing) than tissue from adult and young inice, and indicates that the increase in neuron 
density is the result of shrinkage rather than increase in actual neuronal numbers. Therefore, the 
decrease in Syiiinrn i-atio can be interpreted mainly a s  a decrease in synapse numbers. 
Aged 
55.9k4.1” 
0.001710.0001 
6 
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3.5.1.5 hApoE3 mice 
As only adult hApoE3 mice were available, the effect of aging could not be examined 
for this genotype. 
3.5.2 Discussion 
The main finding of this section is that ApoE genotype influences synaptic plasticity 
associated with aging in the MML of mice. Three main points arose: 
I )  WT mice exhibit very little synaptic changes in the MML during aging 
2 )  Similar to WT inice. ApoE KO inice display no sign of synaptic degeneration 
during aging. 
3) hApoE4 inice exhibit a similar pattern of synaptic changes described in the brain of 
AD patients: a loss of synapses acconipanied by an increase in synaptic area. In 
contrast, there is no synaptic loss in aged hApoE2 mice and only a small decrease in 
synaptic area. 
The lack of major- synaptic changes in the MML i n  aged Wí inice is worth mentioning. 
As yci, ihih is the first descripíion of synaptic moi-phomeiric parameters in the MML of WT 
mice, esiahlished wiih unbiased stereological methods at the EM level. In  CS7BL/6 mice used 
here, only the shaft Syii/nrii ratio shows a dramatic and irreversible 64% decrease between 8 
and 16 months of age. However, this population of synapses represents only a small proportion 
(4 to 9%, throughout life) of the total number of synapses in the MML whereas spine synapses, 
which form the overwhelming majority, are noi affected at all. Similarly, the mean AZ area per 
synapse does not vary with aging. In agreement with this lack of synaptic loss, Calhoun 
(Calhoun et al. 1998a) observed no change in synapiophysin positive presynaptic boutons 
number in DG and CAI during aging in the same strain of mice, arid using stereological 
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counting methods at the light microscopy level. In addition, numbers of DG granule cells and 
CA1 pyramidal cells were remarkably preserved. This lack of synaptic loss in aged mice was 
unexpected and contrasts with observations made in aged rats. Indeed, although aged rats 
display no loss of principal neurons in the hippocampus (Rapp & Gallagher 1996, Rasinussen 
et al. 1996). they lose 24% of spine synapses in the MML and the IML whereas, in contrast to 
C57BL/6 mice. their shaft synapse numbers do not vary significantly (Geinisman et al. 1992, 
Sniith et al. 1999). In both aged monkeys (Tigges et al. 1995, Tigges et al. 1996), and aged 
huinans (Hanios et al. 1989, Lippa et al. 1992, Scheff et al. 1996, Scheff & Price 1998), 
synapse density i5 not altered significantly in the DG. This illustrates great species differences 
in rcsponse to aging (Table 2). However, it is well known from several studies in different 
species other than mice. that some individuals do not show any signiiïcant cognitive or memory 
impairment associated with aging and can be seen as healthy elderly, whereas others develop 
severe deficits (Rapp bt Amara1 1992). Therefore, it cannot he ruled out that the lack of 
synaptic loss observed in mice in this study inay be due to a cluster of ‘healthy aging’ 
indi\~iduals, that may not he a representative saniplc of aging in inice. Morphological studies 
combined with behavioural tests could help res«lve ihis issue. Alternatively, niice from the 
‘aged’ group (74 months olù) inay not be old enough to display evident synaptic changes, the 
mean life span of CS7BL/6 strain being 26-28 months (Jucker bt Ingram 1997). Obviously, 
these points also apply to the other gi-oups of inice included in this study. It is not known if 
unhealthy aniinals were removed from breeding colonies. or if ApoE genotype influences 
inortulity rate and life expectancy in human ApoE transgenic mice. 
ApoE KO mice failed to show any sign of synaptic deficit during aging, as indicated by 
an almost identical pattern of changes to WT mice. The only difference with this latter group 
was a transient increase in mean synaptic area at 17 months of age. The reasons for this effect 
are unclear, and there are no physiological and behavioural data available to correlate with it. 
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One likely explanation could be the fact that mice from the young and aged groups and those of 
the adult group were bred in 2 different places (DUMC. NC, USA and Glaxo-Wellcome, 
Stevenage. UK). Although the breeding conditions were almost identical, uncontrollable factors 
may have influenced this synaptic parameter. Mice from both sources were back-crossed at 
least 6 times to WT animals to reduce possible influence of genetic background (see section 2.1 
for detailed explanation); however, the exact number of back-crossings was not known and 
different numbers may have introduced the sinall variability observed in these results. Two 
studies using other ApoE KO transgenic lines have described up to 40 % loss of synaptophysin 
-positive presynaptic terminals and MAP2 positive neuronal dendrites in the whole 
hippocampus fi-om 3 to 20 months of age (Buttini et al. 1999, Masliah et al. 1995). In contrast, 
authois using the same ApoE KO line as here found no difference in these same measurements 
and in the density of cholinergic fibres in the hippocainpus, in mice as old as 24 months (Fagan 
et al. 1998, Gandy et al. 1995, Parker et al. 1996). Clcarly, these data suggest that, in addition 
to ineasurcment procedures, the nature of the transgenic line may be a crucial factor of 
variability of r e d t s  between laboratories. For example. transgene construct, background strain 
and number uf back-crossings iiiay all contribute i« the observed phenotype. Since other groups 
have described age-dependent degcneraiion in the brain of some lines of ApoE KO mice, it 
seems unreasonable to conclude that ApoE is not involved in brain plasticity. More likely, 
compensatory factors inay account foi- the results presented here (Crawley 1996. Gerlai 1996b, 
Gerlai i996a, Lathe 1996). Like ApoE, both ApoD and ApoJ expression increases in the DG 
after ECL (Bertraiid et al. 1995, May et al. 1990' Tcrrissc et al. 1998), suggesting that these 
lipoproteins could compcnsate for the lack of ApoE for neuronal repair. 
In human transgenic mice, synaptic morphometric parameters were altered in very 
distinct ways, depending on ApoE genotype. Whereas hApoE2 mice displayed no synaptic loss 
and a slight dccrcase in synaptic size during aging. hApoE4 mice lost one third of all their 
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synapses between the young and the aged time-points. Notably, the average synaptic size 
increased with age. Two main conclusions can he drawn from these data: I )  the expression of 
the hApoE2 isoform on an ApoE KO background in hApoE2 mice appears to maintain the 
structural synaptic connectivity during aging. and prevents the important loss of shaft synapses 
observed in ApoE KO and WT mice; 2) the expression of the hApoE4 isoform on an ApoE KO 
background in hApoE4 mice produces a pattern of synaptic changes remarkably different from 
that observed in WT, ApoE KO and hApoE2 mice. If compensatory factors were maintaining 
the number of synapses in aged ApoE KO nuce to prcvent neurodegeneration, it is clear that 
they are not sufficient to counter the effect of the hApoE4 isoform on synaptic plasticity. In 
agreement with these results, Buttini et al (Buttini et al. 1999) reported a significant loss of 
synaptophysin positive presynaptic terminals and MAP?-positive neuronal dendrites in a 
different line of human ApoE4 transgenic mice between the age of 3-4 months and 7-9 months 
(Buttini et al. 1999). The counterbalance of synaptic size against number in hApoE4 mice here 
is very similar to that which Scheff and others described in the OML of the DG (Scheff et al. 
1996) and other cortical areas (Adanis 1987, Bei-toni Freddari et al. 1986. Bertoni Freddari et 
al. 1990. Berioni Freddari el al. 1996b. Bertoni Fieddari et al. 1996a. DeKosky 62 Scheff 1990, 
Scheffet al. 1990. Sclieff &z Price 1993. Scheff& Price 1998) of elderly and AD patients. The 
fact that the totiil AZ area is coiiserved in iheïe cases suggested that the increase in mean AZ 
area reflects an enlargement of the remaining synapses to compensate synaptic loss and 
maintain a level of synaptic transmission. Whether the 22% increase in synaptic size detected 
here is sufficient enough to compensate 34% in synaptic loss is an important issue with regard 
to the functional consequences of such a loss. The total AZ area was calculated here for each 
group. However, this parameter is expressed per unit volume and is therefore biased by tissue 
shrinkage specific to each aye and ApoE genotype. Therefore only total AZ area corrected for 
individual shrinkage allows the comparison of old and young mice with different ApoE 
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genotype. Unfortunately, we were unable to calculate the shrinkage for all of the 76 animals 
and it would be unwise to draw any conclusion for uncorrected data. If antibodies directed 
towards synaptic protein are markers of all synapses, it is reasonable to believe that total 
compensation of synaptic loss by increase of synaptic size would result in no difference in 
inirnunolabelling between young and old animals. Buttini's immunocytochemical study 
(Buttini et al. 1999) indicates that this is not the case between 4 and 9 month old inice. In 
addition, in the frontal cortex of AD patients, up to an approximately 35% decrease in synaptic 
density is compensated by increase in inean synaptic size, after which the total AZ area can no 
longer he maintained (DeKosky & Scheff 1990). Taken together, these findings suggest thdt the 
synaptic enlargeincut observed in aged hApoE4 inice is unlikely to compensate fully for the 
synaptic loss associated with aging. 
The possible reasons and molecular mechanisms for this pattern of synaptic changes 
will be fully discussed later in the general discussion ( Chapter 4). However, two last points 
should be discussed in the context ofthis longitudinal study. 
I )  As an alteimtive to the hypothesis that ApoE4 is il deficient 01- deleterious isoform (see 
Chapter 4 Genei-:il ùiscussion). it may he that its level of expression declines during aging 
whereas that of  other isoforms does not, and that the lack of ApoE results in reduced synaptic 
numbers in aged iiiiiinals. The level of expression of ApoE in these human ApoE transgenic 
mice has not beeii characterised and it is not known how ApoE expression varies with aging, 
and if variation with age depends on ApoE genotype. It has been established that ApoE 
expression increases with aging in the brain of C57BLí6 inice (Masliah et al. 1996). It is 
unclear how ApoE genotype affects ApoE expression in brain cells and CSF of AD patients, 
with authors reporting a reduction (Beffert et al. 1999, Bertrand et al. 1995, Blennow et al. 
1996, Lehtiniaki et al. 1995, Yamada et al. 1995) or no change (Han et al. 1994b, Han et al. 
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1994a, Hesse et al. 1999, Lefranc et al. 1996) in &4 ctirriers cornpared to non-€4 carriers. This 
emphasises the necessity to determine ApoE expression levels during aging in inice carrying 
the 3 ApoE isoforrns to interpret precisely these synaptic changes. 
2) A decrease in the Sydnrn ratio observed in hApoE4 nice can be interpreted in 2 main ways: 
a decrease in synapse density or an increase in neuron density (or a combination of both) during 
aging. Addition~l iiieusurernents of the thickness of the granule cell layer suggested that tissue 
from aged liApoE4 mice shrinks more (either i r r  viiio or during processing) than tissue from 
adult and young inice. The increase in neuron density was therefore the result of shrinkage 
rather than increase in actual neuronal numbers. Consequently, the decrease in synapse per 
neuron ratio observed in these inice is the result of synaptic loss. 
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3.6 ApoE polymorphism differentially influences synaptic 
morphometry in the MML of the DG. 
The same synaptic parameters were compared regarding the ApoE genotype for mice of the 
same age. 
3.6.1 Results 
3.6.1.1 Young mice 
In an initial study. synapse densities were estimated in the MML of the DG and in the 
CAI region of the hippocampus (in the iniddle part of basal aiid apical dendrites of CAI 
neurons) foi- WT and ApoE KO mice. This study was initiated by Masliah’s report (Masliah et 
al. 1995) of gcneral synaptic abnormalities in the fi-onta1 coitcx and hippocampus of young 
ApoE KO inice. 
However, for the 3 regions and for both shaft and synapse densities, no significant 
difference were noted beiween ApoE KO and WT inice (Figure 3.1 I ) .  These results were 
published as pari of a comprehensive study of ApoE KO inice in Anderson et al (Anderson et 
al. 1998). 
When human trmsgenic mice were later perfused. these data were also compared to 
those from IiApoE? aiid IiApoE.1 niice in the DG. IiApoE4 inice appeared to have the highest 
total and spine Sydnrn ratios hui the sinallcst Mean AZJsyn synapse compared to the other 
groups (Figure 3.12). Total and spine Synínrn ratios of hApoE4 mice were 36% and 40% 
greater respectively, than those of ApoE KO mice. However, Mean AZsyn was 28% and 22% 
smallei- in hApoE3 mice compared to hApoE2 and WT mice respectively. The same parameter 
was 18% sinaller in ApoE KO mice compared to hApoE2 mice. 
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3.6.1.2 Adult mice 
hApoE4 mice had the highest shaft Sydnrn ratio of all the groups (Figure 3.13). This 
parameter was significantly greater in these mice compared io hApoE3 (+ 140%), WT (+191%) 
and ApoE KO aniinals (+153%). The patterns of differences for the total and spine Sydnrn 
ratios were very similar. WT and hApoE3 mice had a comparable and smaller Sydnrn ratio 
compared to hApoE2 (-38% and -409’0, respectively) and hApoE4 (-31% and -33%, 
respectively). The mean AZ area per synapse was similar between all the human transgenic 
mice but smaller compared to WT and ApoE KO mice. For hApoE4 mice, this parameter was 
20% smaller in comparison to ApoE KO mice. 
The calculation of tissue shrinkage for hApoE2. E3 and E4 mice allowed the estimation 
of corrected synapse and neuron densities as well as total AZ area per unit volume for a set of 
15-19 month old mice (Figure 3.14). There were no significant differences beiween hApoE2, 
E3 and E4 mice, for any of these parameters. However there was a trend for hApoE2 mice to 
have the highest values of synapse density and total AZ area and these to be smallest in 
hApoE3 animals. 
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3.6.1.3 Aged mice 
The S y d n r n  ratio in hApoE4 inice decreased such during aging that it was 70% and 
275% sinaller than in hApoE2 animals, for shaft and total spine synapses respectively (Figure 
3. IS). Notably, hApoE4 mice had the smallest Sydwn ratios of all groups. ApoE KO mice also 
had 48% less shaft synapses per neuron compared to hApoE2 inice. There was no difference in 
the mean AZ area per synapse among the various groups. 

3.6.2 Discussion 
Thc data presented here demonstrated clearly that ApoE polymorphism differentially 
influcnccs synaptic number and size in the DG of ApoE transgenic mice at the 3 age points. 
Four main conclusions can be drawn and arc discussed in detail below: 
1) There was no sign of synaptic degeneration at any age in ApoE KO mice compared to W' ï  
mice. as indicated by similar synaptic number and size. 
2) The hApoE4 isoforin does not seem to affect the nornial development of hippocampal 
structure and circuitry in young animals. as indicated by normal gross morphology of the 
hippocampus and a high Syn/nrn ratio in young hApoE4 mice. 
3) In  aged hApoE4 transgenic mice however, the presence of the &4 allele is associated with a 
low Syiúnrn ratio but similar synaptic area compared to the other groups studied, 
particularly hApoE2 and WT mice. suggesting that global synaptic transmission in the DG 
inay be altered in these aged hApoE4 mice. 
4) At 13-15 months old. hApoE3 inice show very siinilar values of synaptic sire and number 
compared to wild type and ApoE KO mice. but reduced synaptic numbcr compared to both 
hApoE2 and hApoE4 aged-matched mice. 
As previously indicated in section 3.5. I .2, the pattern of synaptic plasticity during aging 
in ApoE KO mice is not different from that of WT mice. In addition, values for synapse 
number and size are similar for both groups at all ages up to 24 months. Therefore, there is no 
ambiguity in the finding that the ApoE KO mice here do not develop neurodegenei-ation in the 
DG. This result contrasts with other reports describing synaptic loss in other lines of ApoE KO 
mice (Buttini et al. 1999, Masliah et al. 1995, Masliah et al. 1997, Masliah et al. 1999, 
Veinbergs et al. 1999. Veinbergs & Masliah 1999) but is in agreement with researchers who 
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failed to detect such a deficit (Anderson et al. 1998. Gandy et al. 1995, Parker et al. 1996, 
Fagan et al. 1998). Possible explanations for these discrepancies were previously mentioned in 
the discussion of section 3.5.1.2. 
A new finding from this section is the fact that young hApoE4 mice had the highest 
total Synínrn ratio but the lowest mean synaptic area compared to hApoE2, WT and ApoE KO 
mice. Other groups have reported decreased labelling of synaptophysin positive presynaptic 
teriiiinals and MAP2 positive neuronal dendrites in  the. hippocampus of identical (Veinbergs et 
al. 1999) and different (Buttini et al. 1999) lines of hApoE4 trmsgenic mice compared to 
hApoE3 aiid WT inice, as soon as 7 months of age. They reported no difference between 
hApoE4 mice and ApoE KO groups. Some of these results can be reconciled with the data 
presented here. The low shaft Synínrn ratio (shaft synapses are localised on dendrites) is 
consistent with reduced MAP2 dendritic labelling in hApoE4 mice. In addition, since the high 
Sydnrn ratio in hApoE4 inice is accoinpanied by u small synaptic size, synaptophysin labelling 
of presynaptic terminais may be globally reduced, as suggested by immunocytochemical data 
(Buttini et al. 1999, Veinbergs et al. 1999). Electron niicroscopy analysis here clearly adds 
pi-ecision to the description of synaptic structural status compared to light microscopy 
iinmunocytochemical experiments. and suggests that decreased immunolabelling of presynaptic 
terminals can not necessarily be intcrpreted as a loss of synapses. However, in the present 
study. young ApoE KO mice had significantly fewer synapses than hApoE4 animals and 
similar synaptic size. This is in contradiction with the absence of difference in dendritic and 
synaptic iminunolahelling between ApoE KO and hApoE4 mice reported by Buttini et al 
(Buttiiii ei al. 1999) and Veinbergs et a1 (Veinbergs et al. 1999). A mixture of genetic 
backgrounds may confound the effect of' the transgene (Gerlai 1996b) and ideally human 
trdnsgenic mice should be compared with ApoE KO littermates. In practice, this requirement is 
cult to hlfi l  and in the present study, it was not possible io Lise littermates. Nevertheless, 
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huinan transgenic mice were compared to a line of ApoE KO mice froin which they were 
produced. In contrast, Buttini et al mixed 2 different ApoE KO lines in their ApoE KO group. 
Veinbergs et al, who included the same huinan transgenic mice used in this thesis, does not 
specify the origin of the ApoE KO line. However, the neurodegeneration they described in 
ApoE KO animals is in contradiction with data provided in this thesis from Maeda ApoE KO 
mice, and suggests that they might have used a different line of ApoE KO aniinals than the one 
used for production of the human transgenic mice. 
In aged hApoE4 mice, the Sydnrn ratio was the lowest compared to hApoE2, WT and 
ApoE KO age-matched mice. In contrast, all these groups did not differ in terms of synaptic 
size. These data are difficult to compare with the literature because, as yet, no study has tried to 
assess the influence of the ApoE2 isoform on synaptic iníegi'ity. Often, groups in liuinan studies 
are designed as &4 positive and €4 negative, and in transgenic mice models only the ApoE3 
isoforin is compared to the ApoE4 one. Although studies of human ApoE transgenic mice have 
not been carried out beyond 12 months of age (Buttini et al. 1999. Veinbergs et al. 1999), their 
results indicate that synaptic integrity in the hippocampus and the frontoparietal cortex is 
affected in hApoE4 nice compared to hApoE3 and WT inicc. There were no aged hApoE3 
mice available foi- the present study. however. in agreement with the 2 other transgenic studies 
mentioned above. a difference in  synaptic iiuinber could be seen between aged hApoE4 and 
WT mice. I n  AD patients, those carrying the €4 allele display less synaptophysin 
iminunoreactivity in the frontal cortex than thosc without the &4 allele (Miller et al. 1994, 
Masliah et al. 1996). Heinonen (Heinonen et al. 19951) observed a similar trend in the 
hippocampus and the EC of AD patients but differences were not significant. In contrast, 
Blennow (Blennow et al. 1996) found no difference in the level of Rab3 immunoreactivity in 
the IML of the DG associated with ApoE genotype. As yet, no study has examined the effect of 
ApoE polymorphism on synaptic integrity in non-deinented elderly. Since the ~2 allele may 
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have a protective role against AD (Corder et al. 1994, Lippa et al. 1997), it is intriguing that 
aged hApoE2 transgenic mice have the highest number of synapses and that, consistently, mice 
carrying the &4 allele associated with a high risk factor of AD (Saunders et al. 1993a), have the 
lowest number (27% fewer synapses than the hApoE2 mice). Such an effect and its possible 
functional consequences will be discussed in detail in the general discussion ( Chapter 4). 
Two major points that may have influenced these data, showing marked differences 
between hApoE2 and hApoE4 transgenic mice, should be discussed. First, 2 different 
investigators estimated synapse densities in both lines. This could have potentially introduced 
some bias and produced false positive or negative significant results. However, both 
investigators carefully agreed on criteria to count synapses, and checked that their counts were 
matching for 2 animals. Therefore, bias introduced by investigators is unlikely. Secondly, both 
transgenic lines express a different number of copies for the ApoE gene. hApoE2 mice possess 
8 copies whereas hApoE4 mice have 2, with more ApoE being produced in hApoE2 mice than 
in hApoE4 mice (Xu et al. 1995). I t  is arguable that less ApoE protein available to cells may be 
associated with a failure to maintain synapse number, and affect age-related synaptic changes, 
in comparison with lines that produce more ApoE, and irrespectively of the isoform. Although 
such a quantitative effect cannot be ruled out, there are indications from this study and from the 
literature that the identity of the isoform is crucially linked to the effects observed under 
experimental conditions. Ti1 favour o i  this argument, this study showed that only hApoE4 mice 
are unable to maintain synapse numbers during aging. In contrast, ApoE KO mice, which 
express no ApoE, do not exhibit such age-related changes suggesting that the level of ApoE 
expression is not an issue. 
At 14-18 months old. hApoE3 mice showed very similar values of synaptic size and 
number compared to those of WT and ApoE KO mice, but reduced synaptic number compared 
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to both hApoE2 and hApoE4 aged-matched mice. From the results of Buttini and Veinbergs’ 
work (Buttini et al. 1999, Veinbergs et al. 1999), a better synaptic integrity was expected in 
hApoE3 compared to hApoE4 mice. However, the data prescntcd in section 3.5.1.4 showed that 
the synapse per neuron ratio in hApoE4 mice continues to decline beyond 14-18 months of age, 
suggesting that a difference between hApoE3 and hApoE4 mice may emerge later in life. The 
hypothesised differential capacity for maintenance of synaptic integrity of the 3 ApoE isoforms 
inay be revealed at an older age, when synaptic and neuronal injuries are more frequent. It is 
also iiiiportant to incntion that although size and number of synapses are good indicators of 
synaptic wiring, they do not indicate the degree of efficacy of synaptic transmission. It has been 
suggested that a number of synaptic proteins (neurotransmitter receptors, synaptic vesicles 
proteins, for example) might be up-regulated to coinpensate synaptic loss and maintain synaptic 
transmission (Barnes 1994, Barnes 1999). Electrophysi«I«gical investigations in the PP of 
huinaii ApoE iransgenic nuce would help deterinine if the efficacy of synaptic transmission 
differs between hApoE3 and hApoE4 transgenic mice. 
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3.7 Note on the influence of gender on synaptic plasticity 
Sexual differentiation in the brain occurs early in life, during early prenatal or postnatal 
development. The hippocampus is one region to exhibit sexually dimorphic features of its 
structure and function (Desmond & Levy 1997). With regard to the siructure of DG, males of 
some strains of mice with large numbers of granule cells have more granule neurons than 
females (Tanapat et al. 1999, Wimer & Wimer 1985). In rats, inales have more mossy fibres 
synapses in the hilus (Parducz & Garciasegura 1993) whereas females have more mossy fibres 
synapses in the CA3 region (Madeira et al. 1991). Several studies have also demonstrated the 
influence of ovarian steroid hormones on hippocampal structure and function in adulthood. In 
the CA I region, dendritic spine and synapse densities correlate positively with estrogen levels, 
after experimental manipulations and in response to natural fluctuations in females (Desinond 
¿? Levy 1997, McEwen et al. 1997, Woolley et al. 1990, Woolley & McEwen 1992). Similarly, 
in adult female rats, granule cell proliferation correlates with circulating estrogen levels 
(Tiinapat et al. 1999). 
Although this is still controversial, wonicn generally show a higher rate of incidence of 
AD compared to men (Bickebolleï ei al. 1997. Farrer et al. 1997, Poirier et al. 1993b). Whilst 
this observation has no clear basis, the fact that estrogen replacement therapy lowers the risk of 
AD in women (Kawas et al. 1997, Tang et al. 1996) suggested that the loss of estrogens at 
menopause may be crucial. Interactions between estrogen changes and AD pathology are not 
well known. A rccent study showed that estradiol inhibits Aß peptide secretion in cultured 
neurons (Xu et al. 1998a), supporting the idea that estrogen loss may contribute to AD 
pathology. 
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A direct comparison of &4 heterozygous men and women revealed a significant 2 fold 
increase of AD risk in women (Payami et al. 1995, Payanii et al. 1996 but see Corder et al. 
199Sb). It is of particular interest that ApoE expression is regulated by estradiol in astrocytes 
and microglia in female rats (Stone et al. 1997, Stone et al. 1998). Namely, ApoE mRNA levels 
increase at proestrus concomitantly with high concentrations of circulating estradiol and intense 
synaptogenesis in the CAI region of the hippocampus and in the arcuate nucleus of the 
hypothalamus (Stone et ai. 1997). 
Taken together, these findings suggest that both gender and ApoE polymorphism may 
influence the synaptic plasticity associated with aging in the hippocampus of ApoE transgenic 
mice. The groups of animals used in this thesis were composed of males and females, with a 
large male dominance. It would have been interesting to segregate males and females into 
groups of equal size to explore both the effects of ApoE genotype and gender on synaptic 
plasticity associated with aging. Since aniinal numbers were reduced, it was necessary to group 
both sexes together for the general analysis (sections 3.5 and 3.6). However. for interest, this 
section of the thesis analyses trends associated with gender on a subset of mice, and confirms 
that the results obtained in aged animals arc still valid for only-male groups. 
3.7.1 Results 
For this malysis. a subset of hApoE2, E3 and E4 mice were used. Age was the criteria 
to choose the animals. Since females ;ire menopausal at approximately the age of 12-14 months 
(Silver 1995). all the animals under 14 months of age were excluded. This ruled out the 
possible influence oî hormonal variations (which could not he monitored) on structural synaptic 
and neuronal plasticity in the DG of females. 
Two-way ANCOVA (using age as a covariate) showed that both ApoE genotype and 
gender had a significani effect (p=0.003 and p=O.OOI respectively) on Sydnrn ratio, but that 
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there was no interaction between genotype and gender (p=0.438). ApoE genotype and gender 
had no significant effect on mean AZ area per synapse (p=0.4 and p=0.23 respectively). 
Sydnrn ratio and mean AWsyn were subsequently compared between females and 
males for individual transgenic line. The results of'the statistical analysis are presented in Table 
9. 
I female I 2353 0.01 88 15 
male 2642 0.0215 13 17.6 
Gender did not affect the mean AZ area per synapse. In  contrast, it had a significant 
effeci on ilir Syidiirn ratio for hApoE2 and hApoE4 inice but not for hApoE3 inice. In general, 
females had a smaller Sydnrn ratio than males, in the 3 groups of ApoE transgenic mice. 
Sections 3.5 and 3.6 showed that I j the synapse per neuron ratio decreases significantly 
with age only in hApoE4 mice, and 2 )  that aged hApoE4 mice had a smaller Sydnrn ratio 
compared to hApoE2. Since groups used for this analysis were mixed in gender (and had 
different ratios of inale/femalej. results may have been distorted by the presence of females. 
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Therefore, the comparison of adult and aged hApoE4 mice was reanalysed with the exclusion 
of females. The previous result was reinforced: aged hApoE4 inales had a 36 % smaller 
synapse per neuron ratio compared to adult hApoE4 niales (p= O.Ol) ,  instead of the 29% 
difference observed between groups of mixed gender (p=0.04). The changes in mean AZ area 
were mildly altered (+77% for mixed groups and + 2.S% for only-male groups). It was not 
possible to remove females from the adult hApoE2 group because of its small size ( I  
male/2fernales). The difference in Syn/nrn ratio betwecn aged hApoE2 and hApoE4 could not 
be affected by gender as both these groups were only composed of males. 
3.7.2 Discussion 
Although this analysis was performed on groups of small size, it  revealed an interesting 
trend. One common observation was a lower Syilinrn ratio in females of all ApoE transgenic 
groups compared to inales. Whilst this might suggest reduced synaptic connectivity in females, 
such conclusions would need confimation with further study. As mentioned previously, a 
reduced Sydnrii ratio inay, for example, be compensated by pre andor postsynaptic changes to 
maintain the same level of synaptic transmission (Barnes 1993. Barnes 1999). Since there was 
no difference in the average synaptic size, small synaptic number did not seem to be 
compensated for by increased synapse size. This niay reflect an absence of reactive synaptic 
plasticity in menopausal females against age-related synaptic loss. This hypothesis is supported 
by findings of a reduction of sprouting after ovariectomy and its reinstatement by estrogen 
replacement (Morse et al. 1986, Morse et al. 1992). Moreover, esti-ogen also regulates grunule 
cells proliferation in the DG of female rats (Tanapat et al. 1999). It is not known how 
neurogenesis of granule cells is affected by menopause, but ovariectomy clearly reduces 
granule cells proliferation. Reduced number of granule cells, but more importantly reduction of 
postsynaptic sites located on their dendritic tree in the MML, may explain why feinale mice at 
menopause have a smaller Sydnrn ratio than males in this study. 
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There are clear indications that estrogen -induced sprouting after ECL operates via an 
ApoE-dependent mechanism. ECL is used as a model of the deafferentation occurring in AD. 
Both in AD and ECL. the loss of PP afferents is followed by compensatory sprouting in the ML 
of DG. Most ApoE KO mice are deficient for this sprouting response (Anderson et ai. 1998, 
Fagan et al. 1998, Krzywkowski et al. 1999, Masliah et al. 1996, Teter et al. 1999a). Whereas 
estrogen replacement restores synaptic sprouting in the ML of DG in ovariectomized WT mice, 
it does not in ovariectomized ApoE KO inice (Stone et al. 1998, Teter et al. 1999a). This 
suggests that estrogen stimulates sprouting through up-regulation of ApoE expression (Stone et 
al. 1997). 
A recent study using hippocampal slices in  culture taken froin ApoE KO mice showed 
that ApoE3 added to culture medium restores sprouting whereas ApoE4 is only half as efficient 
(Tetei- et al. 1999b). Unfortunately, the results presented here are based on very small samples 
and cannot reasonably be used for coniparison of fcnialcs with different ApoE genotype to 
identify a possible interaction of gender with ApoE polyniorphism. Other reports from human 
AD patients and ApoE transgenic models have shown respectively reduced neuronal 
remodclling and reduced GAP43 iininunoreactivity in various brain regions of &4 individuals 
(Arendt et al. 1997, Veinbergs et al. 1999), suggesting that presence of the &4 allele may be 
associated with inipaired sprouting. The combined effect of  an estrogen deficient state with the 
influence oftlie &3 allele on reactive synaptic plasticity and neuronal repair may account for the 
increased risk of AD in &4 females. 
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3.8 Influence of ApoE polymorphism on glutamate immunolabelling 
in the neuropil of the MML. 
Glutamate is an amino acid with multiple biological roles and it is almost omnipresent 
throughout the hippocampus. As well as being part of a metabolic pool in all cells, it is also 
used as a neurotransmitter in various populations of neurons. Therefore in both cases, 
glutamate is essential to the maintenance of neuronal activity. 
In neurons. glutamate is present in different compartments and cellular regions where it 
plays various roles. In synaptic terminals, the amino acid is contained in synaptic vesicles, 
ready for extracellular release. Presynaptic depolarisation triggers a cascade of events that leads 
to the release of  glutamiite in the synaptic clefi which then binds to a variety of postsynaptic 
receptors to mediate its effects. The excess of glutamate present in the exti-acellular space is 
removed rapidly by an uptake transporter into glial cells, where it is converted into glutamine 
by glutuinine synthetase. The adequate rcplcnishiiient o f  transiriittcr glutainate is assured by the 
iraiisport of glutamine fi-om glial cells to the nerve te¡-niinals where glutamine is converted into 
glutamate by glutaminase (reviewed in (Ereciiiska &L Silver 1990) j .  Iinmunocytochemical 
studies have also located the amino acid in mitochondria and in dendrites. Transport of 
glutainate from the cytosol into mitochondria delivers the substrate to glutamate dehydrogenase 
to provide reducing equivalents for mitochondrial respiration. The reason for the presence of 
glutamate in dendrites is less clear. Since a glutamate transporter has been localised at the 
postsynaptic membrane (Rothstein et al. 1994j, glutamate may be uptaken into spines and 
dendrites to enter the glutamine-glutamate cycle. Another intriguing hypothesis is the use of 
glutamate for local dendritic protein synthesis. An increasing number of dendritic mRNAs have 
been discovered, and the presence of translational machinery in dendrites of hippocampal 
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neurons in culture has been established (Tiedge & Brosius 1996) suppoiting the current view 
that local protein synthesis in dendritic domains serves the management of dendritic protein 
repertoires on site. Additionally, glutamate is involved in many other biochemical pathways, 
notably as a precursor for the inhibiting neurotransmitter GABA (reviewed in (Erecinska & 
Silver 1990)). 
In AD, glutamatergic neurotransmission is severely compromised. Glutamatergic 
neurons and terminals degenerate in the EC and the hippocampus (Braak & Braak 1991, 
Hyman et al. 1984, Pcarson et al. 1985, Procter et al. 1988). The glutamatergic PP arising from 
layer I1 of the EC and terminating on the dendrites and spines of granules cells in the DG is 
particularly affected (Amaral 1995, Hyman et al. 1984). Up to 90% of its terminals are lost 
(Honer et al. 1992b, Sze et al. 1997) and there is an 83% decre,ase in glutamate level in AD 
patients coiripared to aged controls (Hyman et al. 198%). The status of glutamate receptors in 
the pathology is unclear. Generally, most classes of receptors seem to decrease (Aronica et al. 
1998, Cowburn et al. 1988). 
Since possession of the e4 allele is a risk factor foi- AD (Corder et al. 1993) and the 
synaptic connectivity in the MML of the DG is significantly affected in this pathology 
(Heinnnen et al. 1995h, Masliah et al. 1994b). ApoE polymorphism may influence glutamate 
concentrations in the DG. As shown in section 3.6.1.3, aged IiApoE4 transgenic mice have a 
rcduced nuiiiber of synapses per neuron compared io age-matched hApoE2 mice. I n  the present 
part of this study, relative glutamate concentrations wcrc estimated by iiniiiunogold labelling in 
the MML of the DG of aged hApoE2, E3 and E4 transgenic mice to examine a possible 
iniluence of ApoE polymorphism on glutamatergic concentrations in presynaptic houtons and 
dcndrites, since these 2 sites play an important role in neuronal activity and memory formation. 
130 
3.8.1 Results 
For the iinmunocytocheinistry experiment, each transgenic group initially included 6 
mice. One mouse from the ApoE3 giuup was removed froin the final analysis because of the 
absence of iinmunogold labelling which was attributed to inadequate block polyrnerisatioii. 
3.8.1.1 Immunolabelling specificity 
Very low particle densities were found on control sections treated with no primary 
antibody or  with norinal rabbit serum (Figure 3.16) i n  all transgenic groups. Virtually no gold 
particles were seen on resin devoid of tissue such as the lumen of blood vessels, confirming 
that with the chosen experirnental conditions, there was no background labelling. Therefore. 
iinmuiiolalwlìing quantification in the structures of interest (see 3.8.1.3) did not require 
background subtraction. 
3.8.1.2 Qualitative distribution of glutamate immunogold labelling 
In the MML, gold particles were found over neuronal elements (dendrites and 
presynaptic boutons) and glia (Figure 3.17). This distribution did not appear to vary between 
the 3 ApoE trnrisgenic groups. Presynaptic boutoiis displayed lhe highest density of labelling. 
Most labelled synapses were asyinrnetrical and some postsynaptic spines displayed gold 
particles. Even in inice with high iminunogold labelling, not all presynaptic boutons were 
1;ibelled. Occasionally, gold particles appeared on mitochondria contained in synaptic terminals 
and in dendritic profiles. In dendrites, iminunogold labelling was scattered and generlilly much 
lower than in presynaptic boutons. Glial processes in the neuropil were rarely seen and 
displayed little 01- no labelling. 
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hApoE2 
hApoE3 
hA~oE4  
Figure 3.16 Specificity of' glittciniute iniiiiiinogold lcibellirig. On hoth sections incubated either 
without unti-g/idtamute priinury ~intiboùy, or wit/! n o n i i d  rubhit serum instencl of the priinay 
antibody, virtuully no golù  prirticlr Itrhelled tlir tissue. In e.xpritnenta1 sections iricubuted with 
unti-glutuiiirite untiborly, only the neiiropil and presynaptic terminuls (arrows) w e  Iubelled, in 
coiitrmt to tissite-enipQ resin sucli us the liniieri ( / i n )  o f u  blood I J ~ S S ~ ~ .  Scale bur i s  0.5pm. 
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Figure 3.17 Diflerentiul concenírurion.s of gliittnncite iiniizitriogold Iuihelling in the M M L  (f 
ApoE2, E3 uiid E4 aged rrtinsgeizic rriic<.. GIntcirncite iinniuizogold retic.tivify (arro>t~.s) is mninly 
oh.sen~ed in presgiiuptic houtons (h), ussociured with .syntipiic vesicles (urrowheuù). Dendrites 
(di trnd initochontJrici (ni) displayed less dense lcihellirig. Note the greater intensity of 
iinmu~zoltrhelling in pre.rynuptic bonrons in hApoE2 mice cornpcired io IzApoE3 and E4 mice. 
Scale bur is 0.5pm. 
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3.8.1.3 Quantitative evaluation 
Although mice were chosen to be in the same age range, there was a small but 
significant diffei-ence in age between the transgenic groups (see Table 10). 
I Line I n I Age(months) I 
16W.9 
hApoE4 
Since glutainate concentrations, and rcleasc, may vary with age in rodents (Myhrer 
I99X), the 3 transgenic groups were age-matclied foi- the fclllouing statistical analysis, by using 
iiii ANCOVA with age as it covariate. 
Figurc 3.18 shows the mean gold particle density over presynaptic boutons and 
dendritic profilcs in thc MML of aged hApoEi, E3 and E4 transgenic mice. The highest 
number of gold particles for both compartments was found in the hApoE2 group, while 
hApoE3 had thc sniallcst dciisity and hApoE4 an intermediate value. In presynaptic boutons, 
there was a -33% significant difference between hApoE2 and IiApoE3 (p=O.O23) and a -16% 
difference between hApoE2 and hApoE4 mice (non significant). Although a similar pattern 
was found in tlie dendritic compartment, differences were not significant. Notably, gold particle 
density in presynaptic boutons was about twice greater than in dendrites, for all transgenic 
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groups. This is consistent with the view that glutainate serves as a neurotransmitter in 
presynaptic boutons while it may have a metabolic function in dendrites instead. 
Intriguingly. the pattern of differences of total synapse density between the 3 transgenic 
groups mirrored that of both bouton and dendrite gold pai-ticle densities. Synapse density for 
hApoE2 mice was 58% and 21%' higher than that for hApoE3 (p=0.0009) and hApoE4 
(p=O.05 I )  respectively. The relationship between these 2 parameters was confirmed by a 
significant positive correlation (p= 0.014; r= 0.58). Figure 3.19 shows that when all the 
transgenic groups are pooled in one group, inice with small synapse density also display sinal1 
gold particle density. In contrast. mice with high synapse density display high gold particle 
density. but there was no such correlation within individual transgenic groups. This result 
raised an iinportant question: is gold particle density in presynaptic boutons inore influenced by 
ApoE genotype or by synapse density'? The previous regression analysis showed that about 
34% of the  variation in gold particle density is accounted for by the variation in synapse density 
(rL=0.34). To test that ApoE genotype also contributes to the iminunolabelling, differences of 
the mean gold density between ApoE transeenic groups were tested with an ANCOVA, using 
synapse density as a covariate. The analysis denionstrated that a significant difference between 
the ApoE? and ApoE3 groups pcrsists, even when the variations of synapse density are 
removed. This confiriris that there is a 'true' difference in gold particle density between ApoE 
transgenic groups, \vhich is parily accounted lor by ApoE genotype. 
There was no significant correlaiion between synapse density and gold particles density 
in dendrites witliin individual transgenic groups o r  for the whole pool of mice. This last result 
was expected since these 2 measurements are made in independent compartments: dendrites 
present in the MML ai-e likely to arise froin cells of the granule cells layer, whereas synapses 
counted for synaptic density most likely arise from EC cells thut project to the MML. 
I35 
n hApoE2 n=6 
U 
hApoE3 n=5 
hApoE4 n=6 
1 
Figure 3.18 QuantiJcation of immunogold labelling in the neuropil of the MML of the DG of 
human transgenic mice. Gold density is expressed as number of gold particles per p' area of 
presynaptic bouton or dendrite. Synaptic density is expressed as synapses per p3 of tissue. 
Significant diferentes are indicated by an asterisk @0.05). 
SYNVS GOLD 
GOLD = 3 5060 + 2 1627 * SYN 
Correlation r = 58356 
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Synapse density 
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Figure 3.19 Linear regression analysis between synapse densis and glutamate immunogold 
labelling in presynaptic boutons of the MML. Data from ApoE2, E3 and E4 mice were all 
included for this analysis. Density of gold particles and synapses are expressed perp '  and 
p' respectively 
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3.8.2 Discussion 
These results show that ApoE polymorphism in transgenic mice is associated with 
differences in glutamate immunolabelling density in presynaptic boutons and dendrites of the 
MML. 
3.8.2.1 Technical comments 
The validity of these results is discussed and suggests strongly that the observed 
differences in iinmunolahelling reflect ‘true’ physiological differences between the 3 ApoE 
transgenic groups rather than experimental artefacts. Howc\;er, the following caveats should be 
considered. 
I J Possible leciknge of gliiicii?icire withiif and o u i , d e  rhe cell. 
It is conceivable that glutamate from the transmitter or inetaholic pool may have diffused or 
leaked into other cellular compartments before complete fixation of the tissue. However, all the 
animals were perfused rapidly intracardially and for the same amount of time (25 minutes). 
Although it i s  not known if ApoE polymorphism affects tlie quality or speed of tissue fixation, 
it seems unlikcly that tlie hippocanipus, which is a miall sli’ucture (relative to the volume of 
Fixative For intracardial perfusion) and well supplied with blood vessels. would even be affected 
by such differences. 
2 )  E~xpei-imeizi v(wiabili@ 
Sectioiis from each animal and for each transgenic group were treated all simultaneously and 
with the same solutions. to keep the variability of the whole procedure to a minimum. 
3) Specficiíy of labelling 
Parallel control sections demonstrated that both the primay anti-glutamate antibody and the 
gold conjugated antibody were specific. There was virtually no background staining on these 
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sections or on tissue-free resin region of experimental sect ions (even in  mice deinonstrathg the 
highest density of immunogold labelling). 
4 )  Location of image onaljsis 
Presynaptic glutamate immunolabelling has been shown to vary across the outer 2 thirds of the 
ML of the DG, with higher density in the outer ML compared io the middle ML (Bramham et 
al. 1990). I f  images for gold counting were taken outside the MML within one animal or one 
group, gold densities would noi be comparable and bias the results. However, this bias would 
also introduce great variability, which was not observed in the present results. 
5)  Q)umt[ficution of iiizmirnoluhelling 
Finally, the aim of this study was to compare relative imm~inogold particles density, not to 
determine absolute glutamate concentrations. Alíhongh antigen concentration generally varies 
linearly with gold paríicle density, Bramhani (Brainham et al. 1990) also reported a non linear 
i-elalionship between these 2 parameters. This implies that low concentrations of fixed 
glutainaie result in a disproportionately strong labelling compared with higher concentrations. 
If that were the case in this study, differences between the groups would be even more 
pronounced. 
3.8.2.2 Comments on general pattern of immunogold labelling in the MML of DG. 
The pattern of  anti-g1ut;lmate immunogold labelling in the DG and the hippocampus has 
been described extensively by several authors (Bramham et al. 1990, Grandes & Streit 1991, 
Gundersen et al. 1998, Hyinan et al. 1987b, Liu et al. 1989, Wenzel et al. 1997). The labelling 
observed in the present study is in agrecinent with ihese reports. 
In the MML, gold particles were observed in various compartments. The highest density 
was detected in presynaptic terminals, which is consistent with glutamate acting as a 
neurotransmitter in this brain region. The glutamiitergic nature of the PP has been well 
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established with a variety of methods (Grandes & Streit 1991, Nadler et al. 1976, Ottersen & 
Storm Mathisen 1985, Ottersen 1989, Storm Matliisen et al. 1983). Since glutalnate is aiso a 
precursor for the neurotransmitter GABA, some labelled symmetric synapses inay be 
GABAergic rather than glutaniatergic. In these inhibitory terminals, glutamate concentrations 
are then very low, probably due to the rapid conversion into GABA (Ottersen & Storni 
Mathisen 1984, Ottersen 1989, Ottersen & Storm Mathisen 1985). In inice with low 
immunogold density, the results presented here may have been lowered by the presence of 
numerous GABAergic terminals. However, this is unlikcly because GABAergic terminals 
represent a very low proportion of the whole set of terminals in  the MML, normally dominated 
with glutamatergic ones (Amaral 1995, Grandes & Streit 1991). Therefore, even in this extreme 
case, a high proportion of GABAergic terminals would imply that glutamatergic terminals had 
been lost, probably reflecting dysfunction 01- neurodegeneration of glutamatergic neurons. 
Glutamate labelling was also detected in the dendrites present in the neuropil of the 
MML. Its density was about half of that in presynaptic bontons, suggesting that in dendrites, 
dutaniate serves for inetabolism rather than neurotransmission. Most dendrites from the MML 
are likely to belong to glutainatergic granulc cells but there arc also non-glutamatergic cell 
types (see introduction section 1.2.1) contributing to the neuropil connectivity. 
In conclusion, it is reasonable to suggest that most labelled presynaptic boutons use 
glutarnate as their neurotransmitter, whereas labelled dendrites inay reflect the involvement of 
the amino acid for metabolic activity. 
3.8.2.3 Influence of ApoE genotype on glutamate immunogold labelling: possible 
causes and functional consequences. 
As shown in Figure 3.18. glutamate irnmunogold labelling varies with ApoE genotype 
both in presynaptic boutons and in dendritic profiles. Such rcsults have never been reported 
before. The mechanism behind such effects is yet unknown. 
Glutamate can be synthesised via several pathways in neurons (reviewed by (Erecinska 
& Silver 1990). The main source of glutamate at the prcsynaptic terminal site, originates from 
the uptake of glutamine released by glial cells. followed by its conversion into glutamate. 
Variahle amounts of presynaptic glutamate tnay tliereforc be explained by alteration of any step 
in the glutainine-g1ut;imate cycle, although, as yet, there has becn no report of ApoE influence 
on any of these stages. For example. ApoE genotype may modify the availability or the number 
of excitatory amino acid transporters in glial cells or neurons. In the temporal cortex of AD 
patients, up to 60% o f  glutamate uptake sites are lost (Cowburn et al. I 988) and there is an 80% 
loss of glutamate concentrations in the PP teriniiial zone (Hyinan et al. 1987b). 111 both cases, 
these changes detected by light microscopy were interpreted as a consequence of synaptic 
rei-rninal loss. This explanation however does not hold for the results presented here. Glutamate 
concentrations were measured at the EM level, from reinaining synapses and expressed per unit 
area of pi-esynaptic bouton. Therefore, differences in iininunogold labelling between the ApoE 
transgenic groups canii-l be attributed to a difference in synaptic density. The positive 
correlation bctween synapse density and gold particle density suggests that in aniinals with a 
higher synaptic density, high glutainate immunogold labelling may better synaptic 
transmission. 
A speculative explanation for variable glutairiate concentrations between the 3 ApoE 
transgenic groups is that differences in membrane chemical composition and biophysical 
properties may be responsible for variable efficiency of glutamate transporters or vesicle 
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recycling. ApoE is involved in the transport of lipids to regenerating neurons for membrane 
synthesis (Poiricr et al. 1991, Poirier et al. 1993a). Moreover, cholesterol and phospholipid 
concentrations in the CSF are related to ApoE genotype (Yainauchi et al. 1999) and cholesterol 
distribution in synaptic iiiembranes is modified in ApoE knock-out inice (Igbavboa et al. 1997). 
These findings support the view that synaptic membrane composition and biophysical 
properties inay differ between the 3 ApoE transgenic groups, with possible pronounced 
consequences on synaptic transmission (and presynaptic glutamate concentrations). 
Since these relatively aged ApoE transgenic mice have not yet been tested for the 
detection of cognitive or elcctr«physiological deficits, it  is difficult to draw any conclusions 
about the functional consequences of differential glutamate immunolabelling. At the 
presynaptic level, decreased glutamate content intuitively suggests decreased 
neurotransmission. Electrophysiological experiments should be able to verify this hypothesis. 
In favour of this argument, presynaptic axons in the spinal cord of the lainprey which are 
adapted to high level activity, contain higher glutamate concentrations than axons adapted to 
low-level activity (Shupliakov et al. 1992, Shupliakov et al. 1995, Shupliakov et al. 1997). 
However, tlicre is an alternative hypothesis that glutamate level in boutons is low as a 
consequencc of intense synaptic activity that depletes the vesicular content in neurotransmitter. 
Such effects hiivc hcen previously observed after lesion of the nigrostriatal pathway (Meshul et 
al. 1999) wlicic a decrcasc in prcsynaptic teriniiial labelling was accompanied by an increase in 
extracellular glutamate. if this was the case in mice with low glutamate labelling (and low 
synapse density too), increased synaptic activity could be interpreted as a compensatory 
mechanism against synaptic loss. Coinpensatory inechanisins have been described in detail in 
Barnes’ electrophysiological experiments in the hippocampus of aged rats (Barnes 1994). 
While synaptic numbers decrease with aging in the MML, the synaptic strength of the 
remaining synapses is increased. However, this was shown to be due to greater postsynaptic 
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responses rather than increase in quantal release of transmitter. These findings therefore argue 
in  favour ofpooi- neurotransinission in mice with poor glutamate immunogold labelling. 
The glutamate pool measured in dendritic profiles also varied with ApoE genotype. 
This inay reflect various degrees of cellular activity or cellulu ‘health’. Low concentrations of 
glutamate in dendrites may be associated with reduced local dendritic protein synthesis. 
Incidentally, long term potentiation, which is considered as a inodel for the cellular changes 
associated with memory formation (Bliss & Collindridge 1993), is dependent on protein 
synthesis. Thus it is conceivable that alteration of protein synthesis in dendrites may also 
impair the mechanisms of memory formation in the hippocampus. 
Whether biiniìar ApoE-dependent glutamate coilcentrations can be observed in other 
hippocampal regions such as CAI. and whether it is associated with behavioural and cognitive 
deficits remains to be determined. As yet, no major cogiiitive differences have been reported 
between ApoEli and ApoE4 male and young transgenic inice (Raber et al. 1998, Veinbergs et 
al. 1999). 
Other neurotransmitter disorders have been reported in ApoE deficient mice. The 
cholinergic system is one of the most affected but there seein to be strain differences (Anderson 
Kc Higgiiis 1997. Chapman & Michaelson 1998, Fagan et al. 1998, Gordon et al. 1995, Gordon 
ci al. 1996b. Iu-zywkowski et ill. 1999). Cliapinan and Micliaelson (Chapman & Michaelson 
1998) also described decreased synaptic densities for noradrenergic and serotonergic 
pro,jections. with longer pathways being more affected. Although they interpreted their results 
as a loss of presynaptic terminals, they measured only the binding of radioligands specific of 
noradrenergic and serotonergic transporters. This suggests that again, there might be a 
relationship between ApoE genotype and nuniber o f  neurotransniitter transporters. 
142 
In  conclusion, ApoE polymorphism is associated with variable glutamate 
immunoreactivity in the neuropil of the MML of aged ApoE transgenic mice. Although the 
incchanism behind this effect is unknown, ApoE role in lipid transport may be associated with 
variable chemical composition of cellular membrane and may be responsible for reduced 
neuronal glutamate concentrations. Neurotransrnission may be rcduccd in hApoE3 and hApoE4 
mice compared to hApoE2 inice, with possible cognitive and behavioural deficits. 
I43 
Chapter 4 Discussion 
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4.1 Summary 
The aim of this thesis was to determine the influence of ApoE polymorphism on typical 
synaptic markers of neuropathology, such as synapse number and size, in the DG of human 
ApoE transgenic mice. Both a longitudinal and cross-sectional analysis of this aging study 
demonstrated contrasting effects of mouse ApoE, and human ApoE isoforms on synaptic 
PkdStiCity. 
Both WT and ApoE KO mice displayed no major changes in synaptic size or number in 
the MML of the DG with aging. While such a finding is in agreement with a previous report for 
WT animals, the lack of effect in ApoE KO mice demonstrates that KO animals sometimes fail 
to provide informative data about the missing gene. However, other lines of ApoE KO mice 
used by other groups exhibit synaptic degeneration, suggesting that compenmtory mechanisms 
most likely account for the lack of effect observed here. 
In contrast, clear differences appeared during aging between the human ApoE 
transgenic mice, with opposite patterns of synaptic plasticity in hApoE2 and hApoE4 mice. 
Whereas hApoE2 mice maintained a high number of synapses of smaller size even late in life, 
hApoE4 mice seemed unable to do so and displayed severe synaptic loss associated with an 
increase in synaptic size. This correlation between bize and number resembles that observed in 
aged human and AD patients. However, only in AD patients is there a massive loss of synapses 
in the MML of the DG, whereas decrease in synapse numbers is not significant in normal 
elderly individuals. This suggests that the pattern of synaptic changes observed in hApoE4 
mice is not only humanised but also closely matches that of AD patients. The cross-sectional 
study showed that at old age, hApoE4 mice have the least synapses, and hApoE2 mice the 
most, compared to WT and ApoE KO mice. Moreover, at 17 months there was a trend towards 
decreased hippocampal size in hApoE4 mice coinpared to hApoE3 and hApoE2 mice. Such 
influences of ApoE genotype on hippocampal volume have also been reported in normal 
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subjects (Tohgi et al. 1997) and AD patients (Geroldi et al. 1999, Lehtovirta et al. 1995), 
enhancing the similar dependence of a wide range of morphological parameters upon ApoE 
genotype, both in huinan ApoE transgenic mice and human individuals. In addition to maintain 
high synaptic numbers, aged hApoE2 mice also displayed higher glutamate immunogold 
labelling in presynaptic boutons and dendrites of the MML, compared to age-matched hApoE3 
and hApoE4 inice. Inmunogold labelling in presynaptic boutons correlated positively with 
synapse density, suggesting that decreased synaptic transmission may add to synaptic loss in 
aged hApoE4 mice. 
Finally, there was very little difference in Iiippocarnpal volume, synapse number and 
size, and glutamate immunogold labelling in the MML of the DG between hApoE3 and 
hApoE4 inice at 17 months old. Because the &4 allele is a risk factor for AD and the &3 allele is 
the most common of all 3 alleles in the general population, most of the literature regarding 
ApoE genotype focused on those 2 alleles, with very little attention given to &2. In  general, 
opposite effects on various parameters (such as AD pathology, neurite growth, infarct size after 
ischemia. cognitive abilities) are described foi. &4 and &3. Although similar results were 
expected in this thesis, the parameters investigated here failcd to distinguish the effects of the 
&4 and &3 alleles. Seventeen months was the age at which all genotypes were available for the 
human transgenic mice with the 3 isoforms. The literature generally describes a gradation of 
effects, with beneficial influenccs for the &2 allele, a niodcrate influence for the &3 allele and a 
deleterious influence for the €4 allele. While marked differences may appear early between the 
&4 and &2 alleles, because they are both at the end ofthe spectrum, this may not be the case for 
the &4 and &3 alleles. It is conceivable that. although hApoE3 and hApoE4 mice provided 
similar data at I7 months, the same animals would display marked differences later in life. This 
hypothesis is supported by the observation that even after 17 months of age, synapse numbers 
continue to decrease by 29% in hApoE4 mice. 
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4.2 Possible mechanisms involved in ApoE-dependent synaptic 
plasticity during aging 
The mechanisms responsible for the various patterns of synaptic plasticity in the 
different lines of transgenic mice are unclear. Of all the functions described for ApoE in the 
general introduction, its interactions with Aß, modulating its clearance, aggregation and 
toxicity are unlikely to he relevant to the effects observed here. Indeed, there has been no report 
of Aß deposition in these human ApoE transgenic mice (Xu et al. 1995, Xu et al. 1996, Xu et 
al. 1998b, Xu et al. 1999a), or in another construct (Smith et al. 1998). Aß toxicity modulated 
by ApoE isoforms (Ma et al. 1996, Miyata & Smith 1996) or direct ApoE toxicity (DeMattos et 
al. 1999, Jordan et al. 1998, Moulder et al. 1999, Tolar et al. 1997) are also unlikely factors. 
There were no obvious signs of neuronal loss in the DG or other hippocampal fields in any the 
human ApoE transgenic lines used here, even in aged animals. However, since synaptic 
terminals in the MML arise from EC cells (Amaral 1995), it cannot be ruled out that synaptic 
loss in hApoE4 mice is the result of EC neuron degeneration, as it may be the case in AD 
(Hyman et al. 1990, Lippa et al. 1992). 
Other properties of ApoE could be involved in the differential synaptic plasticity 
observed here in aged mice. ApoE is known for its role in lipid transport (Mahley 1988). There 
are good indications that reactive synaptogenesis after ECL involves ApoE-mediated transport 
of cholesterol in the MML (Fagan et al. 1998, Poirier et al. 1991, Poirier et al. 1993a. Teter et 
al. 1999b) and that ApoE-induced neurite outgrowth in vitro requires lipids (Bellosta et al. 
1995, Nathan et al. 1994 but see DeMattos et al. 1998). The involvement of ApoE in the 
maintenance of synaptic integrity could therefore occurs at several levels: 
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I) Diflerentiul lipid content oJ’ApoE-enridted lipopr~~ieiri.s 
Only recent studies have examined the lipid composition of ApoE-enriched lipoproteins 
produccd by astrocytes and present in CSF (Fagan et al. 1999, LaDu et al. 1998). Nasceiit 
asti-ocyle lipoproteins contain little COI-e lipid and are discoidal in shape, whereas CSF 
lipoproteins are larger spherical particles with cholesterol ester in their core. It was suggested 
that nascent astrocyte lipoproteins are converted fi-oin discs to spherical particles by acquiring 
cholesterol ester withiii ihc parenchyina of thc CNS before reaching the CSF (LaDu et al. 
1998). hi human transgenic mice, ApoE genotype does not influence the lipid content of 
astrocytic lipoproteins, but lipoprotein lipid seci-etion (particulai-ly cholesterol) is proportional 
to the amount of ApoE secreted by astrocytes (Fagan et al. 1999). In contrast, in humans, the 
CSF of  ~ 2 / ~ 3  carriers contains more cholesterol rind phospholipids than ~ 3 k . 3  cari-iers. which in 
turn conlairis niore of these lipids than ~ 4 1 ~ 3  individuals (Yamauchi et al. 1999). hApoE2 mice 
used in this thesis express inore ApoE than ApoE4 niice, and thus inay produce lipoproteins 
enriched with more lipids than those of hApoE4 mice. suggesting that lipid-dependent 
processes, such ;is neuronal iriembraiie i-epair, may bc affectcd by ApoE genotype. In support of 
this view, nieriibrane lipid cornpo\ition is altered in ApoE KO inice (Igbavboa et al. 1997. 
Loinnitski et al. 1999) and synnptogeriesis after ECL i5 iiiipau-ed in ApoE KO inice (Fagan et 
al. 1998. Poiriei. ei d. 1991, Poirier et al. 1993a, Teter et al. 1999b). Changes in membrane 
perineahility and stability are likely to have conseyucnces on the activity of pre- and post- 
synaptic proteiiis such as receptors and rieurotransinitter iransporters. Increased glutamate 
iiiiinunolabelling in presynaptic boutons and dendrites i n  hApoE2 mice could therefore be the 
result of altered glutamate transport at these sites, as suggested in 3.8. 
2) Diffrreniiril biixiitrg of ApoE-enriched lilmpr-oieirrs to ApoE receptors 
Of all the ApoE receptors as yet identified, only ’2 have been characterised for their binding 
with the 3 ApoE isoforms: in non neuronal cells, ApoE2 is highly defective, in LDL-receptor 
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binding activity (less than 2% of normal ApoE3 activity) (Weisgraber et al. 1982). In contrast, 
ApoE3 and ApoE4 show an equivalent abiliíy to enhance binding and stimulate uptake of ß- 
VLDL by the LRP pathway, whereas ApoE2 is only 40% as active (Kowal et al. 1990). 
Although differential binding to these receptors does not provide evidence of a more efficient 
role in synaptic maintenance for the ApoE2 isoforin compared to ApoE4, other receptors 
expressed on neurons such as ApoER? and VLDLr inay be involved (Christie et ai. 1996, Kim 
et al. 1996, Page et al. 1998) and need ApoE binding characterisation. 
3)  D i ~ ~ r e n i i u l  iiitrcic.ellirlar referition 
The first experiments describing the effects of ApoE isoforins on neurite outgrowth also 
reported differential accumulation of ApoE ia vitro , with greater intracellular accumulation of 
ApoE3 (and to a lesser extent ApoE2), compared to ApoE4 (Ji et al. 1998, Nathan et al. 1995, 
Pitas 1996). This differential retention requires the presence of lipid or a lipoprotein, and is 
mediated primarily by cell surface HSPG, but does not involve the LDL or LRP receptors. 
Preferential release of ApoE4 from the cells results in decreased accumulation of ApoE4 (Ji et 
al. 1998). In the brain of human ApoE transgenic niicc. the intensity of ApoE neuronal 
itnmunostaining varies with ApoE genotype and is particularly strong in hApoE3 mice. As with 
human tissue. granule cells of the DG of transgenic nuce are generally non-immunoreactive, in 
contrast with coi-tical neurons (Xu et al. 1996, Xu et al. 1998b. Xu et al. 1999b, Xu et al. 
1999a). Since synapses in the MML relay affcrcnt inputs from the EC to the spines and 
dendrites of the granule cells. it is inore likely that differences in synaptic plasticity are related 
to variable ApoE expression in EC neurons rather than in DG cells. In addition, several studies 
also indicate an involvement of ApoE of glial origin in synaptic remodelling (Poirier et al. 
1991. Poirier et al. 1993a, Zarow & Victoroff 1998). It would be useiul to characterise the 
precise ~ellular expression of ApoE in relation to ApoE genotype and celi types. it is well 
established that lipoproteins interiialised via the LDL and LRP receptors follow an endocytic 
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pathway that leads to lysosomal degradation (Krieger & Herz 1994). However, it is unclear 
how a portion of ApoE can escape this degradation (DeMattos et al. 1999). One possibility is 
that ApoE is trdpped by cytoplasmic proteins. 
4)  Differ.eiitiuI .. iirirr.nction with cytoskeleton proteins 
I n  1irr.o studies have shown that ApoE3 hinds to the microtubule binding domains of Tau and 
MAP2c, whereas ApoE4 does not (Huang et al. 1994. Huang et al. 1995, Strittmatter et al. 
1994). Moreover, the inhibitory effect of ApoE4 on neurite outgrowth is associated with a 
disruption of microtubules. as demonstrated by immunocytochemical localisation, biochemical 
assay and electron microscopy (Nathan et al. 1995). It remains to determine that ApoE3 
facilitates microtubule formation and neurite outgrowth in vivo , and elucidate the mechanism 
behind the inhihitory effect of ApoE4. The aged brain is likely to undergo physical and 
chemical injuries, and therefore to require structural remodelling in neurons. The inhibitory 
effect oî  ApoE 4 o n  neurite outgrowth could explain why &4 AD patients exhibit significantly 
less plastic dendritic changes in various brain rcgions compared to non-&4 carriers, and 
suggests a reduced capacity of dendritic reorganisation to coiiipensate neuronal loss (Arendt et 
al. 1997). Both in humans and rodents, the DG still undergoes neurogenesis that persists but 
declines with age (Eriksson et al. 1998, Kempermann et al. 1998, Kuhn et al. 1996). This 
suggests that the dcndritic growth during maturation of these new granule cells may be 
modulated by ApoE griivtype. with conscquenccs on the estiiblisliineiit of synaptic circuitry in 
the ML. The combination of neurogenesis and ApoE4 influence on dendritic growth in aged 
hApoE4 micc may result in the loss of synapses observed in the MML. 
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4.3 Functional implications on behaviour and cognitive performance 
in aged individuais 
The DG represents a crucial gate for cortical inputs which are further processed in the 
hippocampus, and transferred to the neocortex foi- long-term storage of memory (Eichenbaum 
et al. 1996). Therefore, disruption of the DG synaptic transmission associated with possession 
of the E4 allele is likely to have consequence on learning and memory in &4 individuals. Even 
in the case of compensatory synaptic enlargement observed in hApoE4 transgenic mice, the 
loss of fine tuning of specific sets of synapses could affect the way new information is stored or 
recalled in the hippocampus. If other coitical regions were to be affected by decreased 
regenerative capacity, more widespread cognitive deficits could result. 
Data from clinical studies in non-demented elderly arc consistent with this view. 
Individuals with the &4 allele have poorer cognitive abilities and memory than non &4 carriers, 
whereas those with the &2 allele perform better than all the other genotypes. In addition, 
subjects with the &2 rillele maintain their cognitive performance at follow-up examination, 
\\liereas those with other genotypes deteriorate with age (Berr et al. 1996, Boiidi et al. 1995. 
Feskens et al. 1994, Helkala et al. 1995. Helkala et al. 1096, Henderson et al. 1995, Hyman et 
al. 199ha, Kulier et ill. 1998, Reed et al. 1994. Soininen & Riekkinen 1996, Yaffe et al. 1997). 
Moreover, animal models of head injury and clinical cases provide further evidence that 
mortality and neurological deficits in survivors are increased in €4 individuals (Alberts et al. 
1995, Chen et al. 1997, Horsburgh et al. 1Y99b, Jordan et al. 1997, Laskowitz et al. 1997, 
Laskowitz et al. 1998, Nicoll et al. 1995, Sheng et al. 1998, Sheng et al. 1999). These data 
show that inheritance of the &4 allele is associated with an increased chance of developing 
cognitive iinpairment and dementia, whereas inheritance of the &2 allele is associated with a 
smaller risk for developing cognitive impairment, independent of the risk to develop AD. 
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Although transgenic studies failed to detect inajor cognitive impairment in young 
hApoE4 inice (Raber et al. 1998, Veinbergs et al. 1999), it is likely that behavioural tasks that 
are dependent on the integrity of the hippocampus. such as the Morris water maze, would 
detect nieniory deficits in aged hApoE4 mice. 
4.4 Conclusions 
This thesis demonstrated that possession of the &4 allele in human transgenic mice is 
associated with a pattern of plasticity that is normally developed by AD patients in the MML of 
the DG in the early stage of the disease. In contrast. possession of the e2 allele prevented 
synaptic loss and was associated with a iiioderate decrease in synaptic size. These results are in 
agreement with the general view that the ~4 allele is deleterious possibly when neuronal repair 
is required, for example after head injury. during aging. or in AD to counter neurodegeneration 
induced by Aß deposition or NiT. Although neuronal repair is the ApoE function favoured to 
explain differential synaptic plasticity here. other incchanisms such as protection against 
oxidative insult or niodulation of glial response againsr iníîarnmation cannot be excluded 
(reviewed in Laskowitz et al. (1998)). 
More work is necessary to characterise this construct of human ApoE transgenic mice. 
However, the set of data presented !lere suggests that ihe hApoE4 transgenic model may reflect 
generally the synaptic pathology occurring in the DG oï AD patients. This is promising for the 
dcveloprnent of better inodels of AD. So far, only good iriodels of Aß deposition have k e n  
obtained (Duff 1998). However, none of these models lead to synaptic loss, neurodegeneration 
(bur see C:illi«uii et al. 1998b3, or formation of N F ï .  Yankner’s group recently showed that 
rodents and primates r e x t  differenily to injection of fibrillar Aß (Geula et al. 1998). Aß 
toxicity and accumulation of phosphorylated Tau were greatei- in aged rhesus monkeys and not 
significant in agcd rats. The lack of neurofibrillary degeneration in APP transgenic mice may 
be due to differcnces between human and murine Tau proteins. In addition, ApoE is normally 
expressed only in glial cells in rodents whereas it is expressed both in neurons and glia in 
humans (Boyles et al. 1985, Han et al. 1994a). 
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Thus transgenic models for human AD may need 10 incorporate specific properties and 
cellular localisation of human gene expression in order to model the disease accurately. 
Multiple íransgenic mice expressing human APP. ApoE and Tau isoforms may provide a better 
resetnblaiice with AD pathology. 
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4.5 Future directions 
Several experiments can be suggestcd to validate and expand on the results presented here. 
4.5.1 Quantification of ApoE expression in human ApoE transgenic mice 
One source of concern for the interpretation of these results was the variable level of 
ApoE expression in the different lines of ApoE transgenic mice. The literature strongly 
indicates that it is the identity of each ApoE isoforin that is relevant to the specific and 
differential effects observed in experimental situations. Hou,ever, it cannot be ruled out that 
variable expression of ApoE protein is partly responsible for the differences in synaptic 
plasticity during aging ohserved between hApoE2 and IiApoE4 mice. In addition, it is not 
known if ApoE expression varies with increasing age. and if this variatiori is affected by ApoE 
genotype. Therefore, the quantitation of ApoE expression in the brain of thesc human ApoE 
transgenic mice is essential to permit detailed interpretation of  the results presented here. 
Western blots could be used to examine glohal expression in the brain and in the hippocampus. 
In addition. precise ApoE expression and cellular distribution could he quantified by 
iinmunogold luhelling. in the satlie way that relalive gluiainate concentrations were estimated 
in section 3.8. 
4.5.2 Quantification of EC neurons number in human ApoE transgenic mice 
One hypothesis p i 1 1  forward in section 4.2 w ~ s  íhaí synaptic loss occurring in the MML 
of aged hApoE4 mice is the result of EC neuron degeneration. This could be tested by counting 
EC neuron!, for each human ApoE transgenic line. The synapse per EC neuron ratio could then 
be calculated and compared between lines. The relationship between EC neuron numbers and 
synapse density and their variation with age would provide some information about which of 
these 2 parameters is affected first and if they vary to the same extent. 
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4.5.3 Assessment of dendritic integrity in DG granule cells of human ApoE 
transgenic mice 
As an alternative, or in addition to EC cell loss in hApoE4 mice, altered dendritic 
branching of DG grmule cells may be responsible for the decrease in synapse number. Arendt 
(Arendt et al. 1997) demonstrated that dendritic growth is severely deficient in other neuronal 
populations than the DG in €4 AD patients compared to lion-€4 carriers. This suggests that DG 
granule cells in hApoE4 mice may similarly be affected. The pattern of dendritic branching 
co~ild be assessed by stereological methods applied to Golgi-stained preparations. 
4.5.4 Assessment of cholinergic integrity in the hippocampus of human ApoE 
transgenic mice 
The cholinergic system is dependent on lipid delivery for synthesis of ACh (Nitsch et 
al. 1992). €4 AD patients show a reduced activity of the enzyme responsible for the synthesis of 
Ach, ChAT, reduced nicotinic receptor binding sites (Arendt et al. 1997, Poirier et al. 1995 but 
see Svensson et al. 1997). and reduced number of cholinergic neurons in the nucleus basalis of 
Mcyncrt compared to n o n - ~ 4  carriers (Arendt et al. 1997, Poirier et al. 1995 but see Salehi et al. 
1998). To test whether thehe human ApoE transgenic mice provide a good model of cholinergic 
status in hurnans. some of the paranieters iiientioncd above could be assessed. The DG and 
particularly its IhlL rcceive abundant cholinergic projections froin the septum and the diagonal 
band of Broca ( .~I l~a ia i  1995). I n  normal aged individuals and some AD patients, this region is 
very reactive to EC deafferentation and responds with compensatory synaptogenesis extending 
across the ML (Deller & Frotscher 1997, Geddes et al. 1985, Hyman et al. 1987a). It was 
suggested that &4 cai-riers are impaired for such reactive plasticity. Estimation of synapse 
density in the IML and ChAT/AchE (two enzyrncï involved in ACh metabolism) iininunogold 
labelling quantitation could test this hypothesis. 
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4.5.5 Study of the influence of ApoE polymorphism on synaptic transmission 
and cognitive performance in hApoE mice 
The main result of this thesis is the inability of aged hApoE4 transgenic inice to 
maintain a constant synapse per neuron ratio in the MML, in contrast to WT, ApoE KO and 
hApoE2 inice. The consequences of such effects are still unknown and could be examined with 
electrophysiological and behavioural experiinents. Several parameters of synaptic transmission 
could be determined iii the MML by stiinulating the PP. LTP of the PP is another model 
coininonly used to assess the poiential for synaptic p h i c i t y  at the synaptic level. From a 
behavioural point of view, several hippocairipal-clepeiident learning tasks such as the Morris 
water niaze provide information about cognitive status. Such experiments have already been 
carried out in  the same inice as those used in this thesis (Veinbergs et al. 1999) and in another 
construct (Raber et al. 1998). but at an early agc point (3-12 months) when synapse numbers 
have not yet declined in hApoE4 inice. Ideally, experiments should be carried out at a young 
and aged time-points to establish potential cognitive impairment. and examine the2 correlation 
with synapse nuiiihers in  the DG or other regions. It wo~ild be interesting to determine if there 
is great inter-individual variability of cognitive decline in aged inice, as there is in rats, 
irionkeys arid humans (Ritpp b;: Aniaral 1992, Rapp & Gallagher 1996, Rasinussen et al. 1996). 
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Appendix 
Rinsinx suline solution for perfusion 
0.9% sodium chloride solution 
For 1 O O m l  
-Add 0.9g NaCI to 1OOml  of distilled water 
0.1M Phosphate buffer (PB) pH 7.4 
Prepare stock solution of 0.2M PB 
For 100ml 
-Add 0.4978 of NaHzP04.H20 to 2.3288 of Na2HPOd in 100ml of distilled water 
Add equal amount of distilled water to 0.2M PB to obtain O .  1M PB 
Fixaiive solution for EM 
2% Paraformaldehyde 2% Glutaraldehyde 0.1M Phosphate buffer 
For 1 O O m l  
-Add 2g pardormaldehyde to 35ml distilled water and 0.5nil of approximately 1M 
NaOH (made fresh each rime hy dissolving S pellets of NaOH in approximately 5 
ml of distilled waterì 
-Heat the paraformaldehyde solution in a fume cupboard to 60°C until the 
paraformaldehyde dissolves 
-Cool and add 8ml of EM grade 25% glutaraldehyde 
-Make up to 50ml with distilled water 
-Make up to 100ml with 0.2M PB pH 7.4 
-Filter before use in animals 
Stuining solution fo r  volume estimation using Cavalieri ‘s method 
0.01 % toluidene blue solution 
For 1OOml  
Add 0.01 g of toluidene blue powder to 100ml of O. 1M PB 
Resin for  tissue embedding 
Epon resin (medium hardness) 
For 38ml 
-Warm to 60°C for at least 10 minutes: 
glass cylinder 
mixing container (plastic disposable bottle) 
stock bottles of Epon resin (Agar loo), DDSA and MNA 
-Pour 20ml of Agar 100 resin (24g) into cylinder, add 16mi of DDSA (16g) and 
8inl of MNA (log) and pour into mixing container. Mix by rotating gently by hand 
for 1-2 minutes, then piace on the rotator for 10 minutes. 
-Add 1 . 3 d  of BDMA accelerator (3%). Mix as before for 1-2 minutes by hand, 
then place on the rotator for 10 minutes. 
Tissue post-fixcition, dehydrcirion und embedding for  electron rnicroscopy 
Post-fixation of fixed tissue: 
Buffer wash 2x 10 min 
Post-fixation in l%Osmium tetroxyde 
Buffer wash 10min 
I hour 
Dehydration and infiltration in resin 
Both are performed with a Lynx microscopy tissue processor: 
1. 30% acetone 
2. 50% acetone 
3. 70% acetone 
4. 90% acetone 
5 .  100% acetone 
6. 100% acetone 
7. 100% acetone (molecular sieve) 
8. 50:SO Epon: acetone (moi. sieve) 
9. 60: 40 Epon: acetone (moi. sieve) 
IO. 70: 30 Epon: acetone (mol. sieve) 
I l .  80: 20 Epon: acetone (mol. sieve) 
12. Epon 
10 min 
20 min 
20 min 
20 min 
20 min 
20 min 
20 inin 
3 h  
3 h  
3 h  
16 h 
6 h  
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
20°C agitation 
Embedding 
Embed in fresh Epon resin in polythene capsules with paper labels with codes 
written in pencil 
Polymerisation 
Polymerise at 60C for 24-48h 
Preparutiori of solution for support films for  ultrathin sections 
1.5 % piolofnrm in Analar chloroform 
Add 1OOmi of Analar chloroform to 1.5g of pioloform 
Leave overnight to dissolve 
Adjust concentration with Andar chloroform to obtain films of silver-gold 
interference colour. 
EM stuining of ultrathin sections 
Staining is performed in LKB ultrastainer with Leica commercial stains: 
Wetting step 
Ultrastain I :  Uranyl acetate 
Ultrastain 2: Lead citrate 
Wash step in de-ionised water 
50 min 35°C 
10 min 20°C 
Staining solution for  lighf microscopy 
1 %Toluidene blue 5 %Borax 
For 100ml 
Add Ig of toluidene blue to 5g of horax in 100ml of distilled water 
Stir and heat to dissolve 
Filter 
Solurions,fhr Post-embedding inimLtnocytochemistry 
Weigh:8g of NaCl 
0.2g of KC1 
1.15g of Na2HP04 
0.2g of KH2P04 
Add to I litre of distilled water 
Check pH is 7.4 
Blocking upents 
5% BSA/PBSA 
for 20ml 
Add l g  bovine serum albumin (BSA) to 201d PBSA 
Leave overnight to dissolve 
Microfilter before use 
5% BSA/2%NGS/PBSA 
for 20ml 
Add 4 0 0 ~ 1  of normal goat serum (NGS) to 2011 of microfiltered S%BSNPBSA 
Buffer for u~itinen unmuskinn procedure 
0.01M sodium citrate buffer pH6 
For 100ml 
-Prepare stock solutions A and B (100ml each): 
-solution A = 0.2M Na2HP04 
add 2.838 of NaiHP04 to 10Oml of distilled water 
-solution B = 0. 1 M citric acid 
add 2. lg  of citric acid to 100ml of distilled water 
-Add 63.lml of solution A to 36.9ml of solution B 
